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Chapter I 
 
INTRODUCTION 
 
Cell Migration: Cell migration is central to numerous biological processes 
including embryogenesis, the inflammatory response, tissue repair and regeneration, as 
well as pathological processes such as cancer, arthritis, and atherosclerosis 
(Lauffenburger and Horwitz 1996). Nevertheless, despite its importance, the molecular 
mechanisms that control cell migration remain poorly understood.  
Cell migration may be viewed as a multi-step cycle (Figure 1), which begins with 
extension of an actin rich protrusion (Wang 1985; Carson, Weber et al. 1986; Borisy and 
Svitkina 2000). This protrusion is then stabilized by the formation of adhesions, which 
are points of contact between the cell and the extra-cellular matrix (ECM), near the 
leading edge of the protrusion. These adhesions transmit the necessary forces to serve 
as traction points required to move the cell body forward (Lee, Leonard et al. 1994; 
Galbraith and Sheetz 1997; Beningo, Dembo et al. 2001). In turn, the adhesions at the 
leading edge of the cell must disassemble for migration to continue (Laukaitis, Webb et 
al. 2001; Webb, Donais et al. 2004). The process of adhesion assembly and 
disassembly at the leading edge is termed adhesion turnover. Release of adhesions and 
retraction at the rear completes the migratory cycle (Lee, Ishihara et al. 1993; Sheetz 
1994; Lauffenburger and Horwitz 1996).  Since adhesion dynamics play such an 
important role in regulating cell migration, I will focus mainly on this aspect of migration 
in this dissertation. 
 Cell Adhesion - formation and composition: Small nascent adhesions, which 
are less than the 0.25 m resolution of most light microscopy techniques, form 
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Figure 1. The migration cycle. (1) Cell migration begins with the extension of an actin 
rich protrusion. (2) This protrusion is then stabilized by the formation of cell-matrix 
adhesions. (3) The cell body then translocates in the direction of migration. (4) Finally, 
the adhesions at the cell rear detach and the cell retracts. Reprinted from Molecular 
Biology of The Cell, Alberts 4th Ed.  
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concurrently with lamellipodial protrusion (Choi, Vicente-Manzanares et al. 2008). Some 
of these will further mature into focal complexes (0.5 m) and then to focal adhesions 
(FAs) (1-5 m) (Choi, Vicente-Manzanares et al. 2008). This dissertation will focus 
mainly on FAs.  FAs are points of contact between a cell and the ECM (for example, 
fibronectin (FN)), which link the extracellular environment with the actin cytoskeleton 
(actin stress fibers terminate at adhesion sites). They are highly complex and are 
composed of more than 180 different protein-protein interactions (Zaidel-Bar, Itzkovitz et 
al. 2007; Zaidel-Bar and Geiger 2010). However, adhesion proteins fall into some 
general classes (Figure 2).  
The physical link between the ECM and a cell is mediated by the integrin family 
of transmembrane receptors, which are composed of - and -integrin heterodimers 
(Hynes 2002). The extracellular integrin domains bind directly to motifs within ECM 
proteins, such as FN, while the short intracellular tail domains interact with various 
adhesion proteins (Hynes 2002). One major category of adhesion molecules is adaptor 
proteins, such as paxillin, talin, vinculin and zyxin (Brown and Turner 2004; Zaidel-Bar, 
Itzkovitz et al. 2007; Kanchanawong, Shtengel et al. 2010). They act as signaling and 
scaffolding proteins, linking integrins to the cytoskeleton and recruiting other molecules 
to adhesions. For example, talin links the cytoplasmic tail of integrins to actin as well as 
vinculin (Campbell and Ginsberg 2004). Vinculin binds actin and -actinin (an actin 
binding/bundling protein) (Otey and Carpen 2004; Ziegler, Liddington et al. 2006). There 
are also other actin regulatory proteins present, such as vasodilator-stimulated 
phosphoprotein (VASP), which is involved in actin nucleation and binding (Harbeck, 
Huttelmaier et al. 2000). Kinases, such as focal adhesion kinase (FAK), Abelson kinase 
(Abl) and Src kinase, regulate adhesion signaling by phosphorylating many adhesion 
components, such as paxillin and Cas. This localizes guanine nucleotide exchange 
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Figure 2. Schematic of focal adhesion architecture and composition. Integrin 
extracellular domains interact with the ECM, while their cytoplasmic tails interact with the 
integrin signaling layer (including FAK and paxillin). There is then a force transduction 
layer, including talin and vinculin. Finally, there is an actin regulatory layer, which 
includes zyxin, VASP and -actinin which link the adhesion to an actin stress fiber. 
Figure reprinted from (Kanchanawong, Shtengel et al. 2010). 
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factors (GEFs) and GTPase-activating proteins (GAPs), which regulate Rho family 
GTPases (for example, Rho, Rac and Cdc42), and, in turn, modulate adhesion assembly 
and disassembly (Parsons 2003; Defilippi, Di Stefano et al. 2006; Mitra and Schlaepfer 
2006; Peacock, Miller et al. 2007). 
Adhesion Turnover: Polarized cell migration requires asymmetric dynamics of 
cell-ECM adhesions (Figure 3) that are closely coupled to reorganization of the actin 
cytoskeleton. Migrating cells continuously form and disassemble their adhesions at the 
leading edge in a process termed adhesion turnover (Webb, Parsons et al. 2002). 
Nascent adhesions at the cell front exert tractional forces on the substrate that lead to 
cell relocation (Beningo, Dembo et al. 2001). While the majority of nascent adhesions 
undergo rapid turnover such that their components can be incorporated into newly 
formed adhesion sites, a few mature behind the leading edge in response to tensile 
stress (reviewed in (Bershadsky, Balaban et al. 2003)). Mature adhesions are, in turn, 
either disassembled underneath the approaching cell body or diminished to form fibrillar 
adhesions, which play critical roles in extracellular matrix modifications (Zamir, Katz et al. 
2000; Rid, Schiefermeier et al. 2005). 
Once formed, nascent adhesions either turnover or undergo maturation. The 
molecular basis of this choice has received a great deal of attention over the last several 
years because of its central role in cell migration. Locally regulated FAK appears to be a 
key trigger for adhesion turnover. Fibroblasts from FAK null mice have an increased 
number of large, peripheral adhesions (Ilic, Furuta et al. 1995). Local rises in Ca2+ 
concentration can induce adhesion disassembly by increasing the residency of FAK at 
these sites (Giannone, Ronde et al. 2004). In addition, FAK downstream pathways can 
cause a decrease in local myosin contractility. For example, FAK stimulates adhesion 
disassembly through a signaling pathway that includes extracellular signal-regulated 
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Figure 3. Model of asymmetric adhesion dynamics. Nascent adhesions formed at the 
front either undergo turnover, which is predominantly controlled by kinase signaling, or 
mature in response to contractile forces. Mature adhesions can be transformed into 
fibrillar adhesions. Trailing adhesions arise as a result of fusion of additional nascent 
adhesions and remaining fibrillar adhesions. Once formed, trailing adhesions slide 
because of tension from attached stress fibers and either eventually disassemble or 
detach in the form of membrane ‘footprints’. Reprinted from (Broussard, Webb et al. 
2008). 
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kinase (ERK) and myosin light chain kinase (MLCK) (Webb, Donais et al. 2004). FAK 
can also facilitate adhesion disassembly through phosphorylation of Src and 
p190RhoGAP, which decreases the activity of Rho and Rho kinase (ROCK) and recruits 
a complex containing a Rac and Cdc42 GEF, PIX, and an effector, p21-activated kinase 
(PAK), to adhesions (Schober, Raghavan et al. 2007). Thus, FAK downregulates 
myosin-generated tension at the leading edge either by influencing MLCK or by tilting 
the Rho/Rac antagonistic interplay toward Rho inhibition and Rac activation. These 
findings are in agreement with studies implicating myosin contractility in nascent 
adhesion formation (Rottner, Hall et al. 1999; Gupton and Waterman-Storer 2006). 
Mechanistically, the regulation of adhesion turnover modulates the relative rates 
of association versus dissociation of molecules at adhesion sites. Downstream targets of 
Src and/or FAK kinase activity often regulate the recruitment of protein complexes to 
adhesions. The phosphorylation of paxillin kinase linker (PKL) promotes the binding of 
PKL to the adaptor paxillin (Brown, Cary et al. 2005). Paxillin is present early in adhesion 
formation and can stimulate the formation of adhesions. However, paxillin likely induces 
adhesion turnover depending on its phosphorylation state (Nayal, Webb et al. 2006; 
Zaidel-Bar, Milo et al. 2007). PKL and another family member, GIT1, are part of a larger 
protein complex containing PIX and PAK that are targeted to forming adhesions through 
their interaction with paxillin (Brown, Cary et al. 2005; Nayal, Webb et al. 2006). 
Besides phosphorylation-dependent regulation, it is likely that proteolysis of 
adhesion components can also contribute to the turnover process. Talin proteolysis by 
calpain has been shown to stimulate the dissociation of several major adhesion 
components, including paxillin, vinculin, and zyxin (Franco, Rodgers et al. 2004). In this 
case, FAK signaling to talin is able to stimulate adhesion growth. FAK promotes talin 
association with the type I phosphatidylinositol phosphate kinase isoform-g661 
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(PIPKIg661), which ultimately results in the local generation of PI(4,5)P2 leading to the 
recruitment of additional proteins to adhesions (Ling, Doughman et al. 2002). Calpain 
serves to resist this unusual FAK activity and stimulates adhesion turnover. 
Tyrosine phosphatases also play a role in determining whether adhesions turn 
over or mature. For example, protein tyrosine phosphatase 1B (PTP1B) is principally 
associated with the cytosolic face of the endoplasmic reticulum (ER) and travels to sites 
of newly forming adhesions through projections of the ER, which are dependent on 
microtubules (Hernandez, Sala et al. 2006). The maturation of these adhesions is 
inhibited in PTP1B deficient cells, probably because of a loss in the activation of PTP1B 
substrates, such as Src (Hernandez, Sala et al. 2006).  
Coupling of adhesions with the contractile actin cytoskeleton: Initiation of 
adhesion formation is closely coupled with actin assembly in protruding regions of cells 
and requires activation of the same Rac or Cdc42 regulatory pathways as Arp2/3-
dependent actin polymerization. The Arp2/3 complex is recruited to adhesion sites 
during initial stages of assembly through a transient interaction with vinculin in a PI3K 
and Rac1 dependent manner (DeMali, Barlow et al. 2002). Additionally, efficient 
adhesion assembly requires the actin-binding protein, cortactin, which could affect 
adhesion assembly by interacting with the Arp2/3 complex (Bryce, Clark et al. 2005). 
Adhesions that do not turn over at the leading edge mature by increasing in size 
and molecular composition. A major trigger of adhesion maturation is an increase in 
tensile force through interactions with the actin cytoskeleton. Accordingly, proteins that 
produce force by causing contraction, such as both myosin II isoforms (A and B), are 
required for adhesion maturation (Vicente-Manzanares, Zareno et al. 2007). In 
persistently migrating cells, many mature adhesions decrease in size or totally 
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disassemble in the perinuclear region (Rid, Schiefermeier et al. 2005). An important part 
of adhesion disassembly is likely driven by reversing maturation signaling, such as a 
reduction in tensile force because of myosin or Rho inhibition. The interplay between the 
exchange of adhesion molecules and tensile force applied to adhesions is thought to 
play a decisive role in regulating cell migration rates (Gupton and Waterman-Storer 
2006). 
A number of recent findings connect tension with the molecular regulation of 
adhesion assembly. For example, recent work has shown that directional tension on 
integrin cytoplasmic tails triggers the  and  subunits to separate, which could promote 
their activation and recruit cytoplasmic proteins (Zhu, Luo et al. 2008). Tensile force 
directly applied to p130Cas changes its conformation allowing phosphorylation by Src 
family kinases (Sawada, Tamada et al. 2006), which is proposed to stimulate tension-
induced adhesion growth (Geiger 2006).  In addition, force induced unfolding of talin 
stimulates binding of vinculin (del Rio, Perez-Jimenez et al. 2009). Another likely 
mechanism that stimulates adhesion maturation is driven by protein tyrosine 
phosphatase 2 (Shp2), which inactivates FAK by dephosphorylation (von Wichert, 
Haimovich et al. 2003). Dephosphorylation prevents FAK from phosphorylating -actinin. 
Dephosphorylated -actinin, which is able to bind actin, accumulates at adhesion sites 
and establishes a link between integrin-based adhesions and the actin network. This link 
brings tensional force into adhesions, which allows them to mature (von Wichert, 
Haimovich et al. 2003). The extent of coupling between an adhesion and actin transmits 
tensile force to the adhesion and is described as a ‘molecular clutch’ (Figure 4). Such 
coupling plays a critical role in adhesion dynamics at all stages (Hu, Ji et al. 2007).  
Cell protrusion is mediated by the lamellipodium, which is rich in cross-linked, 
dendritic F-actin arrays facilitated primarily by the Arp2/3 complex and cofilin
10 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Schematic of the molecular clutch. (a) At the leading edge, actin monomers 
(blue spheres) are added to the barbed end of the actin filament (arrow). Dark lines are 
integrin transmembrane proteins. (b) If the clutch is disengaged, as actin is assembled 
(blue spheres), the filament moves away from the leading edge due to the force 
generated by the polymerizing actin along with the action of myosin motors (yellow oval). 
This leads to retrograde actin flow. (c) If the clutch is engaged, there is now an indirect 
interaction between the actin filament and the ECM through FA molecules (red and 
green). This restrains the filament allowing new actin polymerization to propel the 
protrusion of the leading edge and the myosin-mediated forces to be transmitted through 
the FA into traction on the ECM. Reprinted from (Gardel, Schneider et al. 2010). 
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(Small 1988; Bailly, Macaluso et al. 1999; Ichetovkin, Grant et al. 2002; Pollard and 
Borisy 2003). Monomers of actin are added to the barbed ends of actin filaments in the 
lamellipodium in a direction facing the leading edge (Okabe and Hirokawa 1991; 
Symons and Mitchison 1991). This generates a pushing force that drives membrane 
protrusion in the direction of migration, while also pushing the actin network away from 
the cell edge, a process is called retrograde actin flow (Heath 1983; Forscher and Smith 
1988; Holifield, Ishihara et al. 1990; Lin and Forscher 1995; Pollard and Borisy 2003; 
Ponti, Machacek et al. 2004). This retrograde actin flow is coupled to the ECM through 
adhesions, which act as a molecular clutch (Mitchison and Kirschner 1988). This allows 
for either the filament polymerization to cause protrusion of the leading edge membrane 
or traction against the ECM to pull the cell body forward via myosin-driven pulling forces 
(Figure 4c) (Harris 1973; Suter and Forscher 2000; Jurado, Haserick et al. 2005). 
Disengagement of the molecular clutch corresponds to increased actin retrograde flow, 
low traction forces and no leading edge protrusion (Figure 4b).  However, high levels of 
engagement lead to diminished retrograde flow, high force generation and leading edge 
protrusion (Figure 4c).  
To date, the best molecular candidates for this clutch are talin and vinculin 
(Calderwood and Ginsberg 2003; Jiang, Giannone et al. 2003; Critchley 2004).  Vinculin 
binds to talin and actin, while talin binds both to actin and the cytoplasmic tail of integrins 
(Kaufmann, Piekenbrock et al. 1991; Gilmore and Burridge 1996; Calderwood, Zent et al. 
1999). The interaction between talin and vinculin is tension dependent, which suggests 
that the strength of the interaction between FAs and actin may intensify under increased 
mechanical tension through a vinculin/talin/actin interaction (del Rio, Perez-Jimenez et al. 
2009). In addition, when talin is depleted, cells exhibit impaired FA formation, an 
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increase in actin retrograde flow and impaired traction capability (Zhang, Jiang et al. 
2008). 
Adhesions in the cell rear: Much less is known about the regulation of trailing 
adhesions as compared to those at the front. It is clear that in persistently moving cells a 
relatively small number of adhesions originating at the leading edge survive disassembly 
and reach the cell rear (Rid, Schiefermeier et al. 2005). There, they increase in size and 
fuse with additional focal adhesions formed at small protrusions around the trailing edge 
as well as with new adhesions formed beneath stress fiber termini (Rid, Schiefermeier et 
al. 2005). Resulting trailing adhesions serve to resist tensile stress induced at the 
leading lamella and support cell spreading. For cell translocation to occur, they must 
move along with the cell body or be released. Adhesion sliding can be accomplished by 
movement of whole adhesions relative to the substrate along with rapid molecule 
exchange at adhesion sites. Fluorescence speckle microscopy (FSM) analysis of 
multiple adhesion proteins suggests that some are coupled with actin movement along 
stress fibers (Hu, Ji et al. 2007), while other components close to the membrane, such 
as integrins, must be exchanged for the adhesion to slide (Ballestrem, Hinz et al. 2001; 
Hu, Ji et al. 2007). 
Adhesion sliding at the trailing edge, although a common phenomenon, is not 
conducive to rapid migration. In migrating cells, trailing adhesions are periodically 
completely detached from the substrate (reviewed in (Kirfel, Rigort et al. 2004)). 
Detachment can be accomplished by actomyosin stress fiber contraction, which requires 
Rho activity (Peacock, Miller et al. 2007) and is likely driven by the MIIA myosin isoform 
(Vicente-Manzanares, Zareno et al. 2007). Before detachment, adhesions must be 
destabilized because a simple increase in tensional force results in a traumatic 
detachment of adhesions from the cell body and a loss of a significant part of the 
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adhesion (Laukaitis, Webb et al. 2001; Peacock, Miller et al. 2007). Destabilization is 
most likely triggered by mechanisms similar to those driving adhesion turn over at the 
cell front. Sometimes, a combination of adhesion disassembly with cell retraction may 
lead to cell detachment even though integrins are still engaged with ECM. In this case, 
patches of membrane are left behind forming ‘footprints’ that have been implicated in 
intercellular guidance (Palecek, Schmidt et al. 1996; Mayer, Maaser et al. 2004). 
Molecular bonds connecting integrins with adhesions are broken at the level of the 
‘molecular clutch’ (Hu, Ji et al. 2007) such that integrins, but not paxillin or -actinin, are 
detached (Laukaitis, Webb et al. 2001). However, many observations argue that 
adhesion destabilization at the rear of motile cells can be significant enough for complete 
detachment of the trailing edge (Kirfel, Rigort et al. 2004; Rid, Schiefermeier et al. 2005). 
Microtubule support of adhesion asymmetry: It is clear that the coordinated 
asymmetry of adhesion disassembly as well as assembly is required for directional cell 
migration. How is the polarized balance of the diverse mechanisms of adhesion 
disassembly and assembly maintained in a motile cell? Microtubules play a key role in 
the polarized distribution of signals within a cell and not surprisingly, have been 
implicated in the asymmetric regulation of adhesion dynamics (Kaverina, Krylyshkina et 
al. 1999). Multiple microtubule targeting of adhesions behind the leading edge or at the 
cell rear leads to their disassembly (Kaverina, Krylyshkina et al. 1999; Rid, 
Schiefermeier et al. 2005). A number of mechanisms have been proposed to explain this 
phenomenon. First, microtubules could facilitate adhesion disassembly by local release 
of tension. Indeed, the tyrosine kinase Arg, which requires microtubules for proper 
localization and activity, can inhibit Rho and p190RhoGAP. Depletion of Arg results in 
the inhibition of adhesion turnover at the front as well as disassembly at the rear 
(Peacock, Miller et al. 2007). Additionally, microtubules could release tensile forces by 
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the uncoupling of adhesion proteins through calpain-driven proteolysis (Chan, Bennin et 
al. 2010). In addition to these processes potentially destabilizing the adhesion structure, 
microtubules can disassemble adhesion components by dynamin-driven endocytosis 
(Ezratty, Partridge et al. 2005). Interestingly, such disassembly requires FAK activity, 
suggesting that dynamin can disintegrate adhesions only in interplay with FAK-induced 
destabilization (Ezratty, Partridge et al. 2005). 
Finally, the ripping off of adhesions by cell edge retraction at the rear may also 
be microtubule dependent since it requires myosin contractility. Contractility is strongly 
regulated by the microtubule-associated Rho GEFs, H1 and Lfc (Glaven, Whitehead et 
al. 1999; Krendel, Zenke et al. 2002). These GEFs reside on the microtubule lattice in an 
inactive form where they can be released and cause local Rho activity upon microtubule 
depolymerization (Zenke, Krendel et al. 2004). Importantly, the microtubule-regulated Lfc 
activity was shown to be essential for cell migration in culture and for morphogenetic cell 
movement in the developing Xenopus embryo (Kwan and Kirschner 2005). 
Though microtubules have been traditionally described in the context of adhesion 
disassembly, they can probably also stimulate adhesion formation and growth. For 
example, since microtubule polymerization activates Rac (Waterman-Storer, Worthylake 
et al. 1999), the persistently growing ‘pioneer’ microtubules at the cell front could induce 
formation of nascent Rac-dependent adhesions (Waterman-Storer and Salmon 1997). 
This function could be accomplished by the activity of Rac and Cdc42 exchange factors, 
ASEFs, which depend on the microtubule plus tip protein APC (Kawasaki, Senda et al. 
2000; Kawasaki, Sagara et al. 2007). The well established microtubule role in the 
delivery of vesicular carriers to the cell front can be implicated in the delivery of adhesion 
components or in the exportation of ECM proteins, which prepares a proper adhesive 
substrate for a moving cell. 
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The ability of microtubules to differentially regulate adhesion dynamics at the 
front and the rear of a motile cell can be explained by the general functional and 
structural asymmetry of the microtubule network. Although microtubules in an interphase 
cell radiate from the cell center to the periphery, their distribution is far from a perfect 
radial symmetry. Indeed, microtubule dynamics in the front half of the cell body are 
characterized by long-lived detyrosinated and/or acetylated microtubule arrays 
(Gundersen and Bulinski 1988), which could serve as preferential tracks for kinesin-
driven transport (Kreitzer, Liao et al. 1999). Diverse plus-end capturing molecular 
clusters (reviewed in (Akhmanova and Hoogenraad 2005; Watanabe, Noritake et al. 
2005)) are located behind the leading edge, in areas of adhesion turnover and 
disassembly and serve as a basis for rapid microtubule rescues and extensive targeting 
of adhesions by microtubules without long depolymerization phases (Rid, Schiefermeier 
et al. 2005). Finally, the extending protrusions, where adhesions are formed, are 
associated with Rac-dependent persistent microtubule growth because of local stathmin 
inhibition (Wittmann, Bokoch et al. 2003; Wittmann, Bokoch et al. 2004). 
In contrast to the front, microtubules at the rear are short-lived and undergo 
frequent Rho-dependent catastrophes of an unclear mechanistic nature (Wadsworth 
1999). Additionally, the front-oriented microtubule array is expanded by a non-
centrosomal population of Golgi-derived microtubules (Efimov, Kharitonov et al. 2007). 
This population depends on a microtubule-stabilizing factor, CLASP, and may bear 
specific properties and/ or functions (Efimov, Kharitonov et al. 2007). The asymmetric 
network of described dynamic properties can serve in the initiation of adhesions in 
protrusive regions of the cell, because of Rac activation and integrin delivery. This 
network can also function in adhesion turnover as well as disassembly behind the 
leading edge and in the cell center (e.g. because of Arg delivery and subsequent local 
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relaxation) and in adhesion destabilization and detachment at the rear by local Arg-
dependent relaxation succeeded by contraction because of GEF release from 
depolymerizing dynamic microtubules (Figure 3). 
Akt and cell migration: Akt is a serine/threonine kinase that was originally 
identified as an oncogene within the mouse leukemia virus AKT8 (Bellacosa, Testa et al. 
1991). Akt is activated downstream of PI3K signaling (Franke, Yang et al. 1995). 
Activation of PI3K generates the second messenger phosphatidylinositol (3,4,5)-
trisphosphate (PIP3) from phosphatidylinositol (4,5)-bisphosphate (PIP2). Akt is 
recruited to the membrane via an interaction between its PH domain and PIP3, and it is 
then activated by phosphorylation by kinases such as phosphoinositide-dependent 
kinase 1 (PKD1) (Kim, Kim et al. 2001). Upon activation, Akt phosphorylates proteins 
and regulates various cellular processes, including cell growth, survival, and proliferation 
(Toker and Yoeli-Lerner 2006). 
Akt is well known for its role in modulating cell growth and survival, but more 
recently, there has been a growing interest in the function of Akt in regulating cell 
migration. Moreover, Akt mutation, usually leading to hyperactivation, is commonly 
reported in human cancers including gastric, breast and pancreatic cancer (Suzuki, 
Freije et al. 1998; Perez-Tenorio and Stal 2002; Schlieman, Fahy et al. 2003; Panigrahi, 
Pinder et al. 2004; Hennessy, Smith et al. 2005). The three isoforms of Akt (Akt1, Akt2, 
and Akt3) appear to play differing roles in regulating cell migration. Akt1 stimulates the 
migration of epithelial cells, fibroblasts, and fibrosarcomas, and promotes the invasion of 
breast carcinomas and fibrosarcomas (Kim, Kim et al. 2001; Irie, Pearline et al. 2005; 
Zhou, Tucker et al. 2006; Ju, Katiyar et al. 2007). These and other properties of Akt1 
point to a central role for this molecule in tumor cell progression and indeed, in mice, 
loss of Akt1 delayed cancer development (Maroulakou, Oemler et al. 2007). In addition, 
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Akt1 is one of the most frequently activated kinases in a number of human cancers 
(Vivanco and Sawyers 2002). The function of Akt2 in regulating cell migration is not as 
clear. Akt2 suppresses the migration of fibroblasts, but promotes motility in a number of 
breast and ovarian cancer cells (Arboleda, Lyons et al. 2003; Irie, Pearline et al. 2005; 
Yoeli-Lerner, Yiu et al. 2005; Zhou, Tucker et al. 2006). The effects of Akt3 on cell 
migration are presently not known. 
Akt regulates the phosphorylation of PAK on serine 21 (Zhou, Zhuo et al. 2003). 
PAK is recruited to adhesions in a complex containing a Rac and Cdc42 GEF, PIX 
(Schober, Raghavan et al. 2007). This phosphorylation event modulates the binding of 
the adaptor protein, Nck, to PAK, which regulates migration (Zhou, Zhuo et al. 2003). 
Nck is important in recruiting paxillin kinase linker (PKL) to adhesions, where it regulates 
cell spreading and motility (Brown, Cary et al. 2005). In addition, PAK induces 
phosphorylation of serine 273 in paxillin, regulating adhesion turnover (Nayal, Webb et al. 
2006). This phosphorylation event increases cell migration, protrusion, and adhesion 
turnover by increasing paxillin-GIT1 binding and promoting the localization of the GIT1-
PIX-PAK complex to the leading edge (Nayal, Webb et al. 2006). 
Akt also plays an important role in metastasis through its ability to regulate 
secretion of matrix metalloproteinases (MMPs). MMPs are responsible for degrading the 
ECM and allowing tumor cells to invade through tissue (Kim, Kim et al. 2001). Akt has 
been shown to regulate the secretion of MMP-9, which promotes migration and invasion 
(Kim, Kim et al. 2001). 
Akt activation requires multiple phosphorylation events including serine 473 and 
threonine 308 (Fayard, Tintignac et al. 2005). However, tyrosine phosphorylation of Akt 
by the non-receptor tyrosine kinase Src has also recently been shown to be important in 
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both the activation of Akt as well as its biological function (Chen, Kim et al. 2001; 
Choudhury, Mahimainathan et al. 2006; Bouchard, Demers et al. 2007). 
Src and migration: Src was the first identified oncogene and tyrosine kinase 
(Martin 2001; Courtneidge 2002). Src regulates many normal cellular processes 
including: cell proliferation and survival, control of cell shape, cytoskeletal regulation, 
adhesions dynamics and cell migration (Thomas and Brugge 1997; Yeatman 2004). Src 
has many important functions in regulating adhesion dynamics and cell migration. The 
cytoplasmic tail of some integrins can interact with Src and activate it, which leads 
ultimately to the activation of Rac and local actin-based protrusion (Huveneers and 
Danen 2009). In addition, FAK is able to recruit Src and Src substrates to sites of 
integrin engagement, and the FAK-Src complex coordinates the assembly and 
disassembly of leading edge adhesions as well as disruption of adhesions in the cell rear 
(Parsons 2003; McLean, Carragher et al. 2005; Berrier and Yamada 2007). Moreover, 
paxillin in adhesions binds to FAK and is subsequently phosphorylated by Src, and 
paxillin can recruit the PAK-PIX-GIT/PKL complex to adhesions, which is important for 
activating Rac and PAK as well as promoting paxillin dissociation, which promotes their 
turnover (Zhao, Manser et al. 2000; Parsons 2003; Hoefen and Berk 2006).  Src mainly 
behaves as a negative regulator of adhesions, as cells deficient in Src show strong 
adhesions, reduced adhesion turnover and impaired migration (Horwitz and Parsons 
1999; Yeatman 2004). 
Moreover, Src deregulation (usually overexpression or hyperactivation) is one of 
the major oncogenic signatures in a large number of human cancers including: breast, 
colorectal, pancreas, prostate, lung, head and neck, melanoma, glioma and different 
types of sarcomas (Summy and Gallick 2003; Bild, Yao et al. 2006; Shor, Keschman et 
al. 2007). Tumor cells must be able to degrade ECM and migrate through tissues to be 
19 
 
invasive, and this function is promoted by invadopodia, which are actin-rich membrane 
protrusions with components similar to FAs (Gimona, Buccione et al. 2008; Buccione, 
Caldieri et al. 2009). Invadopodia accomplish this matrix degradation through the 
recruitment of transmembrane type I MMP (MT1-MMP), which induces localized 
activation of secreted MMP-2 and MMP-9 (Seiki 2003; Steffen, Le Dez et al. 2008). Src 
is a potent inducer of invadopodia formation, as well as a key regulator of invadopodia 
function (Myoui, Nishimura et al. 2003; Artym, Zhang et al. 2006; Rucci, Recchia et al. 
2006; Oser, Yamaguchi et al. 2009; Hu, Mukhopadhyay et al. 2011). Src is also known 
to promote the expression of MMPs as well as inhibit their endocytosis (Hsia, Mitra et al. 
2003; Rivat, Le Floch et al. 2003; Wu, Gan et al. 2005; Meng, Jin et al. 2009; Van 
Slambrouck, Jenkins et al. 2009; Hu, Mukhopadhyay et al. 2011). Interestingly, recent 
work has shown a novel function for FAs, in tumor cells, in degrading ECM, which is 
dependent on Src, FAK, p130-Cas and MT1-MMP (Wang and McNiven 2012). This 
study further blurs the line between FAs and invadopodia. 
The adaptor protein APPL1: Even though kinases and phosphatases have 
received much attention, adaptor molecules are emerging as important regulators of cell 
migration.  These molecules function as integrators of signaling pathways by bringing 
together and targeting protein-binding partners to specific locations within cells. The 
adaptor protein containing a PH domain, PTB domain, and leucine zipper motif 1 
(APPL1) was originally identified through its association with Akt (Mitsuuchi, Johnson et 
al. 1999) and was subsequently shown to interact with transmembrane receptors of 
different classes, including the tumor suppressor DCC (deleted in colorectal cancer), and 
to regulate DCC-mediated signals impacting cell survival (Liu, Yao et al. 2002).  In 
addition, APPL1 also interacts with the small GTPases Rab5 and Rab21 and with the 
Rab effector Oculocerebrorenal Syndrome of Lowe (OCRL), which is an inositol 5-
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phosphatase linked to Lowe syndrome (Miaczynska, Christoforidis et al. 2004; Erdmann, 
Mao et al. 2007; Zhu, Chen et al. 2007). Rab5 has previously been shown to be 
important in regulating actin dynamics, in some cases including the formation 
lamellipodia (Spaargaren and Bos 1999). Recent work has suggested that this effect on 
actin can be mediated through the regulation of the small GTPase Rac, where endocytic 
trafficking of Rac is necessary for the spatial restriction of Rac signaling (Palamidessi, 
Frittoli et al. 2008). This is accomplished by the RacGEF, Tiam1, which is recruited to 
Rab5 early endosomes (Palamidessi, Frittoli et al. 2008). Finally, APPL1 has recently 
been shown to decrease the activation of Akt on phagosomes in a process that is 
dependent on OCRL (Bohdanowicz, Balkin et al. 2012).  
The ability of APPL1 to interact with various signaling and trafficking proteins 
puts it in an ideal position to modulate signaling pathways that regulate cellular behavior.  
Indeed, APPL1 has been linked to cell survival and proliferation (Miaczynska, 
Christoforidis et al. 2004; Schenck, Goto-Silva et al. 2008). In zebrafish, APPL1 has 
been shown to be required for cell survival during normal development, as knockdown of 
APPL1 using morpholinos leads to widespread apoptosis in a process dependent on Akt 
(Schenck, Goto-Silva et al. 2008). Conversely, knockout of APPL1 in mouse showed no 
gross effects on embryonic development or on Akt signaling in T-cells (Tan, You et al. 
2010; Tan, You et al. 2010). Interestingly, thus far, the only observed phenotype in the 
APPL1 knockout mice is an effect on growth-factor induced survival and migration of 
MEFs, which is dependent on APPL1 regulation of Akt signaling (Tan, You et al. 2010). 
However, presently, the function of APPL1 in cell migration is poorly understood. 
APPL1 mediates its function through a series of domains, including an N-terminal 
Bin-Amphiphysin-Rvs (BAR), a central Pleckstrin homology (PH), and a C-terminal 
phospho-tyrosine binding domain (PTB) (Mitsuuchi, Johnson et al. 1999; Miaczynska, 
Christoforidis et al. 2004).  Both the BAR and PH domains are involved in binding to cell 
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membranes. The BAR domain is a dimerization motif associated with the sensing and/or 
induction of membrane curvature while the PH domain binds to phosphoinositol lipids 
(Varnai, Lin et al. 2002; Habermann 2004).  In APPL1, the BAR and PH domains are 
thought to act together as a functional unit forming an integrated, crescent-shaped, 
symmetrical dimer that mediates membrane interactions (Li, Mao et al. 2007; Zhu, Chen 
et al. 2007).  The C-terminal PTB domain of APPL1 has been shown to be critical in 
APPL1’s ability to bind Akt (Mitsuuchi, Johnson et al. 1999; Schenck, Goto-Silva et al. 
2008). 
 
Hypothesis: Cell migration is a highly complex process, which consists of 
membrane protrusion, adhesion, cell body translocation and rear retraction. Adaptor 
proteins are emerging as critical regulators of multiple aspects of the migration process. 
The adaptor protein APPL1 has been shown to be an important regulator of the 
serine/threonine kinase Akt, being able to regulate both its activation and function. Akt is 
a known regulator of cell migration, and we therefore hypothesized that APPL1 can 
regulate cell migration in a process involving modulation of Akt activity and function. 
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Abstract 
APPL1 is a membrane-associated adaptor protein implicated in various cellular 
processes, including apoptosis, proliferation, and survival. Although there is increasing 
interest in the biological roles as well as the protein and membrane interactions of 
APPL1, a comprehensive phosphorylation profile has not been generated. In this study, 
we use mass spectrometry (MS) to identify 13 phosphorylated residues within APPL1. 
By using multiple proteases (trypsin, chymotrypsin, and Glu C) and replicate 
experiments of linear ion trap (LTQ) MS and LTQ-Orbitrap-MS, a combined sequence 
coverage of 99.6% is achieved. Four of the identified sites are located in important 
functional domains, suggesting a potential role in regulating APPL1. One of these sites 
is within the BAR domain, two cluster near the edge of the PH domain, and one is 
located within the PTB domain. These phosphorylation sites may control APPL1 function 
by regulating the ability of APPL1 domains to interact with other proteins and 
membranes. 
Introduction 
Adaptor protein containing a PH domain, PTB domain and Leucine zipper motif 1  
(APPL1) is a 709 amino acid membrane associated protein that has been reported to 
play a key role in the regulation of apoptosis, cell proliferation, cell survival, and vesicular 
trafficking (Mitsuuchi, Johnson et al. 1999; Deepa and Dong 2009). APPL1 is widely 
expressed and found in high levels in the heart, brain, ovary, pancreas, and skeletal 
muscle (Mitsuuchi, Johnson et al. 1999). Although a significant amount of interest has 
been generated in the interactions and function of APPL1, the complete phosphorylation 
profile of this protein has not been described.  To date, phosphorylation of three residues, 
threonine 399, and serines 401 and 691, which were identified from global profiling 
studies (Ballif, Villen et al. 2004; Beausoleil, Jedrychowski et al. 2004; Matsuoka, Ballif 
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et al. 2007; Sugiyama, Masuda et al. 2007; Dephoure, Zhou et al. 2008) are reported in 
protein databases, including Phosphosite, Proteinpedia/Human Protein Reference 
Database, and Expasy-SwissProt. 
 APPL1 mediates its function through a series of domains, including an N-terminal 
Bin–Amphiphysin–Rvs (BAR), a central Pleckstrin homology (PH), and a C-terminal 
phospho-tyrosine binding domain (PTB) (Mitsuuchi, Johnson et al. 1999; Miaczynska, 
Christoforidis et al. 2004). Both the BAR and PH domains are involved in binding to cell 
membranes. The BAR domain is a dimerization motif associated with the sensing and/or 
induction of membrane curvature while the PH domain binds to phosphoinositol lipids 
(Varnai, Lin et al. 2002; Habermann 2004). The BAR domain has also been shown to be 
critical in the ability of APPL1 to localize to endosomal structures (Schenck, Goto-Silva 
et al. 2008). In APPL1, the BAR and PH domains are thought to act together as a 
functional unit forming an integrated, crescent-shaped, symmetrical dimer that mediates 
membrane interactions (Li, Mao et al. 2007; Zhu, Chen et al. 2007). Moreover, the BAR 
and PH domains function together to create the binding sites for Rab5, which is a small 
GTPase involved in endosomal trafficking (Zerial and McBride 2001; Zhu, Chen et al. 
2007). The C-terminal PTB domain of APPL1 has been shown to be critical in the ability 
of APPL1 to bind to several signaling molecules, including the serine/threonine kinase 
Akt, the neurotrophin receptor TrkA, the adiponectin receptors AdipoR1 and AdipoR2, 
Human Follicle-Stimulating Hormone (FSHR), and the tumor suppressor DCC (deleted 
in colorectal cancer) (Mitsuuchi, Johnson et al. 1999; Liu, Yao et al. 2002; Nechamen, 
Thomas et al. 2004; Lin, Quevedo et al. 2006; Mao, Kikani et al. 2006).  
 In this study, phosphorylation sites were identified on APPL1 using contemporary 
MS-based methods, namely by liquid chromatography (LC)-coupled to data-dependent 
tandem MS on both an LTQMS and LTQ-Orbitrap-MS. The bioinformatics algorithm 
SEQUEST was used to process the MS/MS data obtained in these phosphorylation 
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mapping experiments. However, spectral assignments required manual validation of all 
identified phosphorylation site spectra. To obtain near-complete coverage of APPL1, 
multiple proteases were used in parallel phosphorylation site mapping experiments. 
Proteolysis digestion with Glu C, trypsin, and chymotrypsin yielded sequence coverages 
of 44.6%, 88.3%, 81.1%, respectively, with a combined sequence coverage of APPL1 of 
greater than 99%. A total of 13 phosphorylation sites were detected and four of these 
sites were found within APPL1 interacting domains, suggesting a potential regulatory 
role in APPL1 function. 
Materials and Methods 
Reagents and Plasmids: FLAG M2-agarose affinity gel, FLAG peptide 
(DYKDDDDK), and mouse IgG agarose were purchased from Sigma (St. Louis, MO).  
Calyculin A was purchased from Calbiochem (San Diego, CA).  Sodium vanadate was 
obtained from Fischer Scientific (Fairlawn, NJ).  Peroxovanadate was prepared as 
previously described (Posner, Faure et al. 1994).  FLAG-GFP plasmid was prepared by 
inserting the FLAG epitope sequence into pcDNA3 (Invitrogen, Carlsbad, CA) and 
cloning EGFP C1 (Clonetech) into the vector at KpnI and BamHI sites.  Human APPL1 
(accession number GI:124494248) was then cloned into the FLAG-GFP plasmid at 
EcoRI and the insertion as well as orientation of APPL1 was confirmed by sequencing. 
Protein Expression and Proteolytic Digestion: Human embryonic kidney 293 
(HEK-293) cells were maintained in Dulbecco’s Modified Eagle’s Medium (DMEM) 
(Invitrogen) supplemented with 10% fetal bovine serum (FBS) (Hyclone) and 
penicillin/streptomycin (Invitrogen).  HEK-293 cells were transfected with FLAG-GFP-
APPL1 (12 µg per 150 mm dish) using Lipofectamine 2000 (Invitrogen).  After 36 h, cells 
were incubated with 1 mM peroxovanadate and 50 nM calyculin A in DMEM with 10% 
FBS for 30 minutes and extracted with 25 mM Tris, 100 mM NaCl, 0.1% NP-40 (pH 7.4). 
26 
 
The lysates were precleared twice with mouse IgG-agarose for 1 h at 4oC, and 
immunoprecipitated with FLAG-agarose (Sigma, St. Louis, MO) for 2 h at 4oC. Samples 
were washed three times with 25 mM Tris, 100 mM NaCl, pH 7.4 and FLAG tagged 
APPL1 was eluted by incubation of the beads with 0.2 mg/ml FLAG peptide in 25 mM 
Tris, pH 7.4 for 1 h at 4oC. Purified APPL1 protein was subjected to sodium dodecyl 
sulfate polyacrylamide gel electrophoresis (SDS-PAGE) followed by Coomassie blue 
staining.  The concentration of APPL1 was quantified with a LI-COR Biosciences 
ODYSSEY Infrared Imaging System using bovine serum albumin (BSA) as a standard. 
 For MS analyses, APPL1 was separated into three equal aliquots and 
proteolytically digested by trypsin, chymotrypsin, and Glu C proteases, respectively. 
Briefly, proteolysis was performed by taking 2.6 μg of APPL1 (20 μl) and diluting to 25 μl 
with 25 mM ammonium bicarbonate. Cysteine sulfhydryl groups were reduced by the 
addition of 1.5 μl of 45 mM dithiothreitol (DTT) for 30 min at 55°C followed by alkylation 
with 2.5 μl of 100 mM iodoacetamide for 30 min at room temperature in the dark. 
Digestion was performed using 100 ng (1:40 enzyme: substrate, wt:wt) of trypsin gold 
(Promega, Madison, WI), chymotrypsin (Princeton Separations, Freehold, NJ), or 
endoproteinase Glu C (Calbiochem EMD Biosciences, Gibbstown, NJ) at 37°C for 16, 4, 
or 6 h respectively. Proteolysis was quenched by adding 1 µl of 88% formic acid. 
Subsequently, the digest was lyophilized and then reconstituted in 25 µl of 0.1% formic 
acid.  
Western Blot Analysis: Purified APPL1 protein was subjected to SDS-PAGE, 
and then transferred to a nitrocellulose membrane.  The membrane was incubated with 
primary antibody against GFP (Invitrogen) or 4G10 (a kind gift from Steve Hanks, 
Vanderbilt University) at a dilution of 1 µg/ml.  The membrane was then incubated with 
IRDye 800 Conjugated Affinity Purified anti-Rabbit IgG or anti-Mouse IgG (Rockland) at 
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a dilution of 0.1 µg/ml, and visualized using a LI-COR Biosciences ODYSSEY Infrared 
Imaging System. 
Linear Ion Trap and LTQ-Orbitrap MS: LC-MS/MS analyses of APPL1 digests 
were performed using a linear ion trap mass spectrometer (LTQ, Thermo Electron, San 
Jose, CA) equipped with an autosampler (MicroAS, Thermo) and an HPLC pump 
(Surveyor, Thermo), and Xcalibur 2.0 SR2 instrument control. Ionization was performed 
by using nanospray in the positive ion mode. Spectra were obtained by using data-
dependent scanning tandem mass spectrometry in which one full MS scan, using a 
mass range of 400–2000 amu, was followed by up to 5 MS/MS scans of the most 
intense peaks at each time point in the HPLC separation. Incorporated into the method 
was data-dependent scanning for the neutral loss of phosphoric acid or phosphate (−98 
m/z, −80 m/z), for which MS3 was performed. Dynamic exclusion was enabled to 
minimize redundant spectral acquisitions. High resolution data was collected using a 
similar strategy on a LTQ-Orbitrap mass spectrometer with the exception that the full 
MS3 scan was performed in the Orbitrap at 30,000 resolution, rather than at unit mass 
resolution on the LTQMS. Further instrumental details are available in the Electronic 
Supplementary Material. 
Bioinformatic Analysis: Tandem MS/MS spectra acquired in LTQMS and LTQ-
Orbitrap-MS experiments were identified using SEQUEST (University of Washington). 
MS/MS spectra were extracted from the raw data files into .dta format with spectra 
containing fewer than 25 peaks being excluded. Files labeled as singly charged were 
created if 90% of the total ion current occurred below the precursor ion, and all other 
spectra were processed as both doubly- and triply-charged ions. Proteins were identified 
using the TurboSEQUEST version 27 (rev. 12) algorithm (Thermo Electron) and the IPI 
Human database version 3.33 (67837) sequences. Search parameters are outlined in 
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the Electronic Supporting Information. Manual verification was performed on all 
phosphorylation assignments having an Xcorr value above 1, 2, and 2.5 for charges +1, 
+2, and +3, respectively. Validation was performed as previously described.(Nichols and 
White 2009) All spectra are included in the Electronic Supporting Information according 
to MIAPE standards (Taylor, Paton et al. 2007).  
Results and Discussion  
Comprehensive Phosphorylation Map of Human APPL1: In this study, a 
comprehensive phosphorylation profile of APPL1 is described for the first time. To 
accomplish this, FLAG-GFP-APPL1 was expressed in HEK-293 cells and subsequently 
immunoprecipitated for MS analysis according to the purification scheme outlined in 
Figure 5A.  A major band corresponding to the molecular mass of APPL1 was observed 
when the immunoprecipitate was subjected to SDS-PAGE and stained with Coomassie 
blue (Figure 5B).  The band was confirmed to be APPL1 by Western blot analysis 
(Figure 5C).  Before subjecting APPL1 to MS analysis, we examined the phosphorylation 
state of this protein using 4G10 phospho-tyrosine antibody.  APPL1 was phosphorylated 
on tyrosine residues as determined by Western blot analysis with 4G10 (Figure 5C).  
Several other minor bands were detected in the immunoprecipated samples, which 
could correspond to endogenous APPL1 or APPL1 binding proteins. However, 
insufficient peptide signal from MS analyses precluded positive protein identification of 
these additional minor bands.   
At least 13 (as discussed below) phosphorylation sites with 99.6% total amino 
acid sequence coverage were identified using multiple proteases, including trypsin, 
chymotrypsin, and Glu C, followed by LC-MS analyses using both an LTQMS instrument 
and an LTQ-Orbitrap instrument. Of these reported phosphorylation sites, three could 
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Figure 5. APPL1 protein purification. (A) Schematic showing the generalized protocol 
used for purifying FLAG-tagged proteins. (B) SDS-PAGE gel of immunoprecipiated 
FLAG-GFP-APPL1 stained with Coomassie blue. Arrow points to purified FLAG-GFP-
APPL1. (C) Western blot with GFP-specific antibody (left panel) or phospho-tyrosine 
antibody (right panel).  Left panel shows the purified protein is FLAG-GFP-APPL1 (IB: 
GFP) and right panel shows that APPL1 is phosphorylated on tyrosine residues (IB: 
4G10).   
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not be located to a single amino acid (i.e. phosphorylation was determined to exist within 
a range of potential sites within a peptide). 
Table 1 shows each confirmed phosphorylation site assignment by sequence 
position using the LTQMS instrument. In total, ten phosphorylation sites were identified 
by combining the data obtained for trypsin, chymotrypsin, and Glu C digests to obtain a 
sequence coverage of 95.3%. Of these ten sites, only two could not be located to a 
specific residue, i.e. phosphorylation was confirmed to exist between amino acids 97-98 
(SS) and 401-403 (SPS). Table 2 shows the confirmed phosphorylation sites using the 
LTQ-Orbitrap instrument. By combining the data obtained for Glu C, trypsin, and 
chymotrypsin digests, nine phosphorylation sites were identified with a sequence 
coverage of 99.6%. Several of these phosphorylation sites were detected in multiple 
peptides derived from proteolytic miscleavages corresponding to the same site of 
phosphorylation. Of these nine sites, two could not be located to a specific residue, but 
were confirmed to exist between amino acids 401-403 (SPS) and 689-691 (SSS). A 
comparison of the phosphorylation sites identified using the LTQMS and LTQ-Orbitrap 
yielded four unique sites by the former and three unique sites by the later.  We detected 
five phosphorylation sites, including serines 401/403, 459, 691, 693, and 696 by both 
methods.  Interestingly, most of the phosphorylation sites we detected in human APPL1 
are conserved in rat and mouse APPL1 (Table 3), raising the possibility that these sites 
serve a functional role. 
Two of the previously identified phosphorylation sites in APPL1, 401S and 691S, 
were detected in our analysis while one additional site, 399T, was not definitively 
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Table 1. Phosphorylation Sites within APPL1 Identified by LTQMS 
 
Peptides
a 
Sequence 
Position
b
 
 
Protease
c 
 
[M+H]
+ 
(m/z) 
 
92 
VIDELSSCHAVLSTQLADAMMFPITQFK 
119
 ‡ Trp 3175.53 
376 
QIpYLSENPEETAAR 
389
 378Y Trp 1700.75 
390 
VNQSALEAVTPSPSFQQR 
407
 ‡ Trp 2038.99 
456 
DIIpSPVC*EDQPGQAKAF 
472
 459S Chymo 1954.93 
479 
TNPFGESGGSTKpSETEDSILHQLFIVR 
505
 491S Trp 3029.46 
595
 SESNLSSVCpYIFESNNEGEK 
614
 604Y Trp 2315.94 
669 
LIAASSRPNQASSEGQFVVLpSSSQSEESDLGEGGK 
703
 689S Trp 3631.71 
683 
GQFVVLSSpSQSEESDLGEGGKKRE
 706 
691S Glu C 2633.24 
683 
GQFVVLSSSQpSEEpSDLGEGGKKRE
 706 
693S, 
696S Glu C 2713.24 
 
a. "p" denotes phosphorylation, asterisk, “*” denotes carboxyamidomethylation.  
b. “‡” denotes sequence regions where single residue is known to be phosphorylated between 
the residues underlined. Phosphorylation on specific residue on those regions cannot be 
confirmed.   
c. represents digestion by multiple proteases. Trp, Chymo and Glu C correspond to the proteases, 
trypsin, chymotrypsin, and Glu C, respectively.  
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Table 2. Phosphorylation Sites Identified within APPL1 by LTQ-Orbitrap-MS 
Peptide
a 
S
e
q
u
e
n
c
e
  
P
o
s
it
io
n
b
 
P
ro
te
a
s
e
c
 
[M
+
H
]+
 
(m
/z
) 
 
M
a
s
s
 e
rr
o
r 
(p
p
m
) 
 
367 
IC*TINNIpSKQIYLSENPEETAARVNQSAL 
395
 374S Chymo 3356.66 3.30 
390 
VNQSALEAVTPSPSFQQR 
407
 ‡ Trp 2038.96 -2.45 
415 
AGQSRPPTARTSpSSGSLGSESTNL 
438
 427S Chymo 2428.11 -0.62 
418 
SRPPTARTSpSSGpSLGSESTNL 
438 
427S, 
430S Chymo 2251.96 0.93 
418 
SRPPTARTSpSSGSLGSESTNL 
438 
427S Chymo 2171.99 1.10 
451 
TPIQFDIIpSPVC*EDQPGQAKAF 
472
 459S Chymo 2541.17 0.08 
456 
DIIpSPVC*EDQPGQAKAF 
472
 459S Chymo 1954.91 -1.64 
457 
IIpSPVC*EDQPGQAKAF 
472
 459S Chymo 1954.86 0.33 
669 
LIAASSRPNQASSEGQFVVLSSSQSEESDLGEGGK 
703
 ‡ Trp 3631.68 -3.71 
683 
GQFVVLSSpSQSEESDLGEGGKKRE 
706
 691S Glu C 2633.21 -0.46 
683 
GQFVVLSSSQpSEESDLGEGGKKRESE 
708
 693S Glu C 2849.28 5.58 
683 
GQFVVLSSSQpSEESDLGEGGKKRE 
706
 693S Glu C 2633.21 -0.57 
686 
VVLSSpSQSEESDLGEGGKKRE 
706
 691S Glu C 2301.06 0.13 
686 
VVLSSSQpSEEpSDLGEGGKKRE
706
 
693S, 
696S Glu C 2381.03 -1.89 
 
a."p" denotes phosphorylation, asterisk, “*” denotes carboxyamidomethylation.  
b. “‡” denotes sequence regions where single residue is known to be phosphorylated between 
the residues underlined. Phosphorylation on specific residue cannot be confirmed.  
c. represents digestion by multiple proteases. Trp, Chymo and Glu C correspond to the proteases, 
trypsin, chymotrypsin, and Glu C, respectively.  
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Table 3. Comparison of Peptide Sequence Surrounding Identified Phosphorylation 
Sites in APPL1 
Site Position Homologues Peptide Sequence 
‡ 97/98S 92-119 Human VIDELSSCHAVLSTQLADAMMFPITQFK 
Rat VIDELSSCHAVLSTQLADAMMFPISQFK 
Mouse ---------------------------- 
  
374S, 378Y 367-395 Human ICTINNISKQIYLSENPEETAARVNQSAL 
Rat ICTINNISKQIYLSENPEETAARVNQSAL 
Mouse ICTINNISKQIYLSENPEETAARVNQSAL 
  
‡ 401/403S 390-407 Human VNQSALEAVTPSPSFQQR 
Rat VNQSALEAVTPSPSFQQR 
Mouse VNQSALEAVTPSPSFQQR 
  
427S, 430S 418-438 Human SRPPTARTSSSGSLGSESTNL 
Rat SRPPTARTSSSGSLGSESTNL 
Mouse SRPPTARTSSSGSLGSESTNL 
  
459S 451-472 Human TPIQFDIISPVCEDQPGQAKAF 
Rat TPIQFDIISPVCEDQPGQAKAF 
Mouse TPIQFDIISPVCEDQPGQAKAF 
  
491S 479-505 Human TNPFGESGGSTKSETEDSILHQLFIVR 
Rat TNPFGESGGSTKSETEDSILHQLFIVR 
Mouse TNPFGESGGSTKSETEDSILHQLFIVR 
  
604Y 595-614 Human SESNLSSVCYIFESNNEGEK 
Rat SESNLSSVCYIFESNNEGEK 
Mouse SESNLSSVCYIFESNNEGEK 
  
689S, 691S, 
693S, 696S 
669-703 Human LIAASSRPNQASSEGQFVVLSSSQSEESDLGEGGK  
Rat LIAASSRPSQSGSEGQ-LVLSSSQSEESDLGEEGK 
Mouse LIAASSRPNQAGSEGQ-LVLSSSQSEESDLGEEGK 
  
‡ 
689/690/691S 
669-703 Human LIAASSRPNQASSEGQFVVLSSSQSEESDLGEGGK 
Rat LIAASSRPSQSGSEGQ-LVLSSSQSEESDLGEEGK 
Mouse LIAASSRPNQAGSEGQ-LVLSSSQSEESDLGEEGK 
   
 
“‡” denotes sequence regions where single residue is known to be phosphorylated between the 
residues underlined. Phosphorylation on specific residue on those regions cannot be confirmed. 
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assigned.  Phosphorylation of 401S was initially identified in epithelial carcinoma (HeLa) 
cells as part of a large-scale characterization of nuclear phosphoproteins and in an 
analysis of protein phosphorylation in developing mice brains (Ballif, Villen et al. 2004; 
Beausoleil, Jedrychowski et al. 2004). This site was subsequently shown to be 
phosphorylated in HeLa cells in two additional studies (Sugiyama, Masuda et al. 2007; 
Dephoure, Zhou et al. 2008).  Phosphorylation of 691S was detected in HEK-293 cells in 
response to DNA damage using ionizing radiation.(Matsuoka, Ballif et al. 2007) We also 
identified phosphorylation of this site in HEK 293 cells under physiological conditions. 
Phosphorylation at 399T was identified in a global profiling study, but a positive 
identification could not be definitively made in our experiments. Our spectra potentially 
suggested phosphorylation at 399T, but in these spectra, this site was not the highest 
confidence assignment. Furthermore, the previous study examined protein 
phosphorylation during mitosis using HeLa cells arrested in the mitotic phase of the cell 
cycle while our analysis was performed in HEK-293 cells under conditions in which they 
were progressing through the cell cycle. Thus, it is possible that phosphorylation of this 
site is transient if it is regulated by cell cycle progression and difficult to detect. 
Phosphorylation Sites within APPL1 Functional Domains: The confirmed 
phosphorylation sites obtained on both instruments are shown in Figure 6. Of the 
confirmed sites, four were found in APPL1 interacting domains. Namely serines 97/98 
were located in the BAR domain, raising the possibility that phosphorylation at these 
sites could disrupt APPL1 dimerization as well as endosomal localization. Interestingly, 
as shown in the crystal structure of the BAR and PH domains, serines 97/98 are located 
on the concave surface of the BAR domain, which is thought to interact with membranes 
(Figure 7) (Tanabe, Hosaka et al. ; Li, Mao et al. 2007).  Therefore, phosphorylation at 
this site could potentially regulate membrane interactions. Serine 374 and tyrosine 378 
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Figure 6. Map of APPL1 phosphorylation sites. (A) Phosphorylation sites identified in 
APPL1, using LTQMS and LTQ-Orbitrap MS. Underlined sites indicate that one 
phosphorylation is known to exist within the region. (B) A schematic of APPL1 is shown 
with identified phosphorylation sites relative to the position of APPL1 domains. 
Interacting regions within APPL1 for several proteins and receptors are also indicated. 
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Figure 7. Phosphorylation in the BAR and PH domains of APPL1. Crystal structure 
of the BAR and PH domains of APPL1 is shown. Phosphorylation site serine 97/98 and 
serine 374 are highlighted in red and their positions are indicated with arrows. Note that 
although tyrosine 378 neighbors the PH domain, it was not included in the crystal 
structure from the Protein Data Bank (2ELB). 
  
37 
 
are clustered near the edge of the PH domain (Figure 7), suggesting a potential link to 
APPL1 localization. Collectively, these sites in the BAR and PH domains, may contribute 
to altered APPL1 binding to Rab5, since together these domains are important for this 
interaction. Finally, tyrosine 604 was found in the PTB domain, which is typically 
involved in protein-protein interactions, and phosphorylation in this domain may regulate 
the ability of APPL1 to bind to its interacting protein partners. Interestingly, a significant 
number of identified phosphorylation sites are found outside of known domains. Even 
though these sites are outside described domains, it does not imply a lack of functional 
significance. These sites may have importance in regulating the structure and molecular 
interactions of APPL1. 
Putative Kinases for Identified APPL1 Phosphorylation Sites: Table 4 shows 
putative kinases for eight of the identified APPL1 phosphorylation sites obtained using 
NetPhosK 1.0 and Scansite (medium stringency) (Obenauer, Cantley et al. 2003; Blom, 
Sicheritz-Ponten et al. 2004).  These potential kinases include the serine/threonine 
kinases casein kinase 1 and casein kinase 2, which are involved in Wnt signaling 
(Davidson, Wu et al. 2005; Gao and Wang 2006). Casein kinase 1 is predicted to 
phosphorylate serines 430, 693 and 696, while casein kinase 2 is predicted to 
phosphorylate serines 491, 691, and 696. The serine/threonine kinase cell division cycle 
2 (cdc2) is an important regulator of cell cycle progression, and is predicted to 
phosphorylate serines 401, 689, and 691 (Aleem, Kiyokawa et al. 2005). The 
serine/threonine kinase Akt, also known as protein kinase B, binds to APPL1 via the 
PTB domain, and is predicted to phosphorylate serine 427 in the area between the PH 
and PTB domain (Mitsuuchi, Johnson et al. 1999). Moreover, the serine/threonine kinase 
glycogen synthase kinase 3 (GSK3), a downstream effector of Akt, is predicted to 
phosphorylate APPL1 at serine 401 (Cross, Alessi et al. 1995). Putative kinases 
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Table 4. Putative Kinases for Identified APPL1 Phosphorylation Sites 
Sequence  
Position 
MS-based method Putative Kinases
a
 
401 S LTQMS/ LTQ-Orbitrap 
cell division cycle  2 
glycogen synthase kinase 3 
cyclin dependent kinase 5 
427 S LTQ-Orbitrap 
ribosomal s6 kinase 
Akt 
protein kinase A 
 
430 S LTQ-Orbitrap 
protein kinase C 
casein kinase 1 
491 S LTQMS casein kinase 2 
689 S LTQ-Orbitrap cell division cycle  2 
691 S LTQMS/ LTQ-Orbitrap 
casein kinase 2 
DNA protein kinase 
cell division cycle  2 
693 S
 
LTQMS/ LTQ-Orbitrap casein kinase 1 
696 S
 
LTQMS/ LTQ-Orbitrap 
casein kinase 2 
casein kinase 1 
 
a. Kinases predicted to phosphorylate the indicated sites using NetPhosK 1.0 (0.5 threshold) and 
Scansite (Medium Stringency). 
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obtained from Scansite (low, medium, and high stringency) are shown in Table 5. 
Advantages and Challenges to Contemporary Phosphoproteomic 
Methodologies: Figures 8 and 9 demonstrate the necessity of manual verification of 
bioinformatics analyses. For example, the peptide in Figure 8, 
GQFVVLSSSQpSEESDLGEGGKKRE, was identified correctly, but because the 
incorrect peak was used as the monoisotopic peak, the mass error of the precursor ion (-
381 ppm) was outside of the acceptable range (-5 to 5 ppm). Conversely, an example of 
an erroneous SEQUEST assignment is shown in Figure 9. Although b and y ion 
coverage bracketing the phosphorylation site is sufficient for a high X-corr value and 
high sequence coverage confidence, high abundance peaks do not correspond to b and 
y ions or their respective neutral losses. Collectively, these examples and ambiguity 
arising from gas-phase rearrangement illustrate the continuing need to validate 
sequencing data in phosphorylation site mapping experiments (Palumbo and Reid 2008; 
Palumbo, Tepe et al. 2008). 
Conclusion  
Emerging data indicate an important role for APPL1 in regulating various cellular 
processes, such as cell proliferation, apoptosis, and survival, which points to a need to 
gain insight in to the regulation of this protein (Mitsuuchi, Johnson et al. 1999; Deepa 
and Dong 2009). Since phosphorylation is an important regulatory mechanism, we 
generated a comprehensive map of phosphorylation sites within APPL1. We detected 13 
phosphorylation sites within APPL1, with four of these being identified in functional 
domains. These sites have potential implications in regulating APPL1 function and 
interactions, which represents an important avenue for future study.  
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Table 5. Putative kinases determined by Scansite 
Sequence 
Position Putative Kinases Score Percentile Stringency 
427S Akt 0.5939 0.962% medium and low 
430S casein kinase 1 0.3641 0.132% high, medium and low 
protein kinase C delta 0.4422 0.634% low 
protein kinase C epsilon 0.4934 2.673% low 
491S casein kinase 2 0.5636 2.386% low 
689S glycogen synthase kinase 3 0.6119 2.146% low 
691S ataxia telangiectasia mutated kinase 0.5612 1.541% low 
DNA protein kinase 0.6199 3.346% low 
693S casein kinase 2 0.6084 4.799% low 
DNA protein kinase 0.5419 1.027% low 
696S casein kinase 2 0.4160 0.214% medium and low 
 
a. The score values start at 0.000 if the sequence optimally and they increase for sequences as 
they diverge from this motif. 
b. The percentile tells how good a score is for a given motif, the lower the percentile the better the 
score. For example, the cut off value for high stringency is 0.2%. 
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Figure 8.  Tandem MS/MS spectrum acquired using an LTQ-Orbitrap illustrates 
peak validation for accurate SEQUEST assignments. Inset illustrates a situation 
whereby the instrument selected the peak at 878.7426 as the monoisotopic peak 
resulting in erroneous mass accuracy (-381 ppm). Manual validation of the data correctly 
assigns the accurate monoisotopic peak at 878.4084 resulting in a mass accuracy for 
the parent species of 0.56 ppm.  
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Figure 9. Tandem MS/MS spectrum of a phosphorylation site incorrectly assigned 
by SEQUEST. SEQUEST assignments report 15% b-ion sequence coverage and 55% 
y-ion coverage from the y5 ion to the y16 ion. Of the eight most abundant peaks in the 
spectrum, six ions, indicated by an asterisk, correspond to neither b nor y ions, or to 
characteristic neutral losses. Manual verification was performed to detect such errors in 
the bioinformatic assignments. Additionally, the b and y ion coverage fails to bracket the 
suggested sites of phosphorylation, namely tyrosine 378 and serine 380. 
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Abstract 
Cell migration is a complex process that requires the integration of signaling 
events that occur in distinct locations within the cell.  Adaptor proteins, which can 
localize to different subcellular compartments, where they bring together key signaling 
proteins, are emerging as attractive candidates for controlling spatially coordinated 
processes.  However, their function in regulating cell migration is not well understood.  In 
this study, we demonstrate a novel role for the adaptor protein containing a pleckstrin 
homology (PH), phosphotyrosine binding (PTB), and leucine zipper motif 1 (APPL1) in 
regulating cell migration. APPL1 impairs migration by hindering the turnover of 
adhesions at the leading edge of cells.  The mechanism by which APPL1 regulates 
migration and adhesion dynamics is by inhibiting the activity of the serine/threonine 
kinase Akt at the cell edge and within adhesions. In addition, APPL1 significantly 
decreases the tyrosine phosphorylation of Akt, by the non-receptor tyrosine kinase Src, 
which is critical for Akt-mediated cell migration.  Thus, our results demonstrate an 
important new function for APPL1 in regulating cell migration and adhesion turnover 
through a mechanism that is dependent on Src and Akt.  Moreover, our data further 
underscore the importance of adaptor proteins in modulating the flow of information 
through signaling pathways. 
Introduction 
Adaptor proteins are emerging as important regulators of key signaling events 
that control cellular behaviors underlying many biological and pathological processes 
(Flynn 2001).  They can accomplish this, through their multiple functional domains, by 
bringing together and targeting protein binding partners to specific locations within cells 
(Pawson 2007).  This capability places adaptor proteins in an ideal position to integrate 
and direct signals that control highly complex, spatiotemporally regulated processes 
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such as cell migration. Indeed, recent work has pointed to a role for these integrators in 
the regulation of cell migration (Nayal, Webb et al. 2006; Yu, Deakin et al. 2009; 
Meenderink, Ryzhova et al. 2010); however, their function in modulating this process is 
not well understood. 
 APPL1 is a 709 amino acid endosomal protein which was first identified through 
its association with Akt (also known as protein kinase B) in a yeast two-hybrid screen 
(Mitsuuchi, Johnson et al. 1999). APPL1 contains an N-terminal Bin-Amphiphysin-Rvs 
(BAR) domain, a central PH domain, as well as a C-terminal PTB domain (Mitsuuchi, 
Johnson et al. 1999; Miaczynska, Christoforidis et al. 2004).  The BAR domain is a 
dimerization motif associated with sensing and/or induction of membrane curvature 
(Habermann 2004; Peter, Kent et al. 2004; Chial, Lenart et al. 2010).  Similarly, the PH 
and PTB domains of APPL1 have been reported to bind to phosphoinositol lipids (Li, 
Mao et al. 2007; Chial, Wu et al. 2008). The BAR and PH domains of APPL1 cooperate 
to form a functionally unique BAR-PH domain that differentiates it from other members of 
the BAR domain-containing protein family (Li, Mao et al. 2007; Zhu, Chen et al. 2007).  
APPL1 interacts with the early endosomal protein Rab5 via the BAR-PH domain 
(Miaczynska, Christoforidis et al. 2004; Zhu, Chen et al. 2007). Moreover, the PTB 
domain is the critical region of APPL1 that is responsible for binding Akt (Mitsuuchi, 
Johnson et al. 1999).   
 Akt is a serine/threonine kinase that is activated downstream of 
phosphatidylinositol 3-kinase (PI3K) (Franke, Yang et al. 1995).  PI3K signaling recruits 
Akt to the plasma membrane where it becomes activated following phosphorylation on 
two conserved residues, threonine 308 (T308) and serine 473 (S473) (Alessi, 
Andjelkovic et al. 1996).  Interestingly, Akt activation also occurs on signaling 
endosomes, whereby PI3K is recruited to endosomal membranes and promotes the 
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activation of Akt (Wang, Pennock et al. 2002).  Active Akt phosphorylates its 
downstream effectors to regulate several cellular processes including cell growth, 
survival, and proliferation (Manning and Cantley 2007).  Moreover, there has recently 
been a growing interest in the function of Akt in the regulation of cell migration. Akt has 
been shown to stimulate the migration of epithelial cells, fibroblasts, and fibrosarcomas, 
and to promote the invasion of breast carcinomas and fibrosarcomas (Kim, Kim et al. 
2001; Irie, Pearline et al. 2005; Zhou, Tucker et al. 2006; Ju, Katiyar et al. 2007).  
 In addition to the regulatory phosphorylation at T308 and S473, recent work has 
shown that Akt also undergoes tyrosine phosphorylation (Chen, Kim et al. 2001). Akt 
tyrosine phosphorylation is mediated by the non-receptor tyrosine kinase Src (Chen, Kim 
et al. 2001).  Src-mediated tyrosine phosphorylation of Akt is reported to be important in 
both the activation and function of Akt (Chen, Kim et al. 2001; Choudhury, 
Mahimainathan et al. 2006; Bouchard, Demers et al. 2007). However, nothing is 
currently known about the role of Akt tyrosine phosphorylation in the regulation of cell 
migration.  
 Cell migration is initiated in response to an external stimulus and begins with the 
extension of an actin-rich protrusion, which is stabilized by the formation of nascent 
adhesions at the leading edge (Carson, Weber et al. 1986; Zaidel-Bar, Ballestrem et al. 
2003; Ponti, Machacek et al. 2004; Nayal, Webb et al. 2006). These adhesions can then 
mature into large, stable adhesions through subsequent recruitment of signaling, adaptor, 
and cytoskeleton-related proteins, or they can disassemble (Miyamoto, Teramoto et al. 
1995; Zaidel-Bar, Milo et al. 2007; Choi, Vicente-Manzanares et al. 2008; Dubash, 
Menold et al. 2009; Kanchanawong, Shtengel et al. 2010).  For migration to proceed in 
an efficient manner, adhesions at the leading edge of the cell must continually form 
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(assemble) and disassemble in a process termed adhesion turnover (Laukaitis, Webb et 
al. 2001; Webb, Donais et al. 2004; Dubash, Menold et al. 2009).   
 Here we show that the adaptor protein APPL1 is an important regulator of cell 
migration and adhesion dynamics.  APPL1 modulates these processes in a manner that 
is dependent on its ability to regulate Akt activity and function.  Moreover, APPL1 inhibits 
the ability of Akt to promote migration by impairing Src-mediated tyrosine 
phosphorylation of Akt.  
Materials and Methods 
Reagents: An APPL1 rabbit polyclonal antibody was made using the peptides 
CSQSEESDLGEEGKKRESEA and CSQSEESDLGEGGKKRESEA (21st Century 
Biochemicals, Marlboro, MA).  Primary antibodies used for this study include: 
phosphorylated Akt (Thr-308) polyclonal antibody (Santa Cruz Biotechnology, Santa 
Cruz, CA), pan-Akt C67E7, Akt1 C73H10, Akt2 D6G4, and Akt3 62A8 monoclonal 
antibodies (Cell Signaling, Beverly, MA), paxillin monoclonal antibody (BD Bioscience 
Pharmingen, San Diego, CA), phosphotyrosine clone 4G10 monoclonal antibody 
(Millipore, Billerica, MA), β-actin clone AC-15 monoclonal antibody, and FLAG M2 
monoclonal antibody (Sigma, St Louis, MO).  Secondary antibodies used for 
immunocytochemistry were Alexa Fluor 488 and 555 anti-rabbit as well as Alexa Fluor 
488 and 555 anti-mouse (Molecular Probes, Eugene, OR).  Secondary antibodies for 
Western blot analysis included IRDye 800 anti-mouse and 800 anti-rabbit (Rockland 
Immunochemicals, Gilbertsville, PA). Fibronectin was purchased from Sigma (St Louis, 
MO).  Anti-FLAG M2 agarose, mouse IgG-agarose, and PP2 were purchased from 
Sigma (St Louis, MO). 
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Plasmids: Full-length human APPL1 cDNA was produced via reverse 
transcription of HEK293 cell RNA with subsequent amplification with the SuperScript 
One-Step RT-PCR kit (Invitrogen, Carlsbad, CA) using the following primers: 5’-
ATGCCGGGGATCGACAAGCTGCCC-3’ (forward) and 5’-TGCTTCTGATTCTCTC-
TTCTTTCC-3’ (reverse).  Then, the APPL1 cDNA was sequenced and cloned into 
pEGFP-C3 vector (Clontech Laboratories).  Small interfering RNA (siRNA) constructs 
were prepared as previously described (Zhang and Macara 2008). Briefly, sense and 
antisense 64-mer oligonucleotides, containing the 19-nucleotide targeting sequence, 
were ligated into pSUPER vector.  The siRNA oligos targeting sequences included: 
APPL1 siRNA 1, 5’-CACACCTGACCTCAAAACT-3’; APPL1 siRNA 2, 5’-AAGAGTGGA-
TCTGTACAAT-3’; Akt siRNA 1, 5’-GGAGGGTTGGCTGCACAAA-3’; Akt siRNA 2, 5’-
CTACAACCAGGACCATGAG-3’.  APPL1 siRNA 1 and both Akt target sequences have 
been previously described (Miaczynska, Christoforidis et al. 2004; Pore, Jiang et al. 
2006; Degtyarev, De Maziere et al. 2008; Bristow, Sellers et al. 2009). mCherry-paxillin 
was kindly provided by Steve Hanks (Vanderbilt University, Nashville, TN).  DN-Akt1 
(K179A/T308A/S473A) and CA-Akt1 (T308D/S473D) were generously provided by Brian 
Hemmings (Friedrich Miescher Institute, Basel, Switzerland) and Jeffrey Field (University 
of Pennsylvania, Philadelphia, PA). The Akind FRET probe was kindly provided by 
Michiyuki Matsuda (Kyoto University, Kyoto, Japan). GFP-Src-Y527F (CA-Src) was a 
generous gift from Margaret Frame (University of Edinburgh, Edinburgh, UK). The cDNA 
for GFP-APPL1-∆PTB (amino acids 1-466) was generated from full length GFP-APPL1 
using PCR with the following primers: 5’-TCGAATTCGGCTTATGCCGG-3’ and 5’-
TCGGTACCTGGCTACTTCCAAATCCTC-3’. The PCR product was then cloned into the 
pEGFP-C3 vector (Clontech Laboratories) at EcoRI and KpnI.  GFP-APPL1-AAA was 
prepared by site-directed mutagenesis of full length GFP-APPL1 using a Quikchange II 
kit (Agilent Technologies, Santa Clara, CA).  For GFP-APPL1-AAA, the following primers 
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were used to mutate amino acids R146, K152, K154 to alanines:  5’-
CGATTAATGCATATAGCCGTTTATCAGCAAAAGCAGAAAATGACAAGG-3’ and 5’-
GCGATTAATGCATATAGCCGTTTATCAGCAAAAAGAG-3’. HA-FLAG-Akt1 was 
purchased from Addgene (Cambridge, MA).  Akt-Y315F/Y326F and Akt-
T308D/S473D/Y315F/Y326F were generated by site-directed mutagenesis of HA-FLAG-
Akt1 using a Quikchange II kit.  For Akt-T308D/S473D/Y315F/Y326F, the following 
primers were used: T308D - 5’-GGTGCCACCATGAAGGACTTTTGCGGCACA-3’; 
Y315F - 5’-GGCACACCTGAGTTCCTGGCCCCCGAGGTG-3’; Y326F - 5’-CAC-
TGCACGGCCGAAGTCATTGTCCTCCAG-3’; and S473D - 5’-TTCCCCCAGTTCGAC-
TACTCGGCCAGCGGC-3’.  
Cell Culture, Transfection, and Immunoprecipitation: HT1080 cells were 
maintained in Dulbeco’s Modified Eagles Medium (DMEM) (Invitrogen) with 10% fetal 
bovine serum (FBS) (HyClone, Logan, UT) and 1% penicillin/streptomycin (Invitrogen). 
Cells were transiently transfected with Lipofectamine 2000 (Invitrogen) according to the 
manufacturer’s instructions. 
 For immunoprecipitation of Akt, HT1080 cells were co-transfected with 0.5 g of 
FLAG-Akt cDNA and various other cDNA(s) using Lipofectamine 2000. After 24 h, cells 
were incubated with 1 mM sodium vanadate and 2 mM H2O2  (peroxovanadate) in 
DMEM for 15 min and then lysed with 1% NP-40 in 25 mM Tris, 100 mM NaCl, with 
protease inhibitors, pH 7.4.  In some experiments, cells were incubated with PP2 (1 – 
7.5 M) for 1.5 h prior to peroxovanadate treatment. Cell lysates were pre-cleared by 
incubation with non-immune mouse-IgG agarose in 25 mM Tris, 100 mM NaCl, pH 7.4 
overnight at 4oC. FLAG-Akt was immunoprecipitated with anti-FLAG M2 agarose in 25 
mM Tris, 100 mM NaCl, pH 7.4 for 2 h at 4oC followed by elution with 0.2 mg/ml FLAG 
peptide (Sigma, St Louis, MO) in 25 mM Tris, pH 7.4.   
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Migration Assay and Microscopy: Cells were plated on tissue culture dishes, 
which were coated with 2.5 µg/mL fibronectin for 1 h at 37oC, and permitted to adhere 
for 1 h at 37oC in culture media.  Then, cells were imaged using phase contrast 
microscopy on an inverted Olympus IX71 microscope (Melville, NY) with a 10X objective 
(NA 0.3) and a Retiga EXi CCD camera (QImaging, Surrey, BC).  Cells were kept at 
37oC in CCM1 (HyClone) supplemented with 2% FBS (HyClone) at pH 7.4 during 
imaging. Images were acquired at 5 min intervals for at least 6 h, using MetaMorph 
software (Molecular Devices, Sunnyvale, CA).  Cell movement was tracked from the 
time-lapse images using MetaMorph, and migration speed was calculated by dividing the 
total distance moved in microns by the time. Wind-Rose plots were generated by 
transposing X-Y coordinates of cell tracks to a common origin. 
Immunocytochemistry and Image Analysis: Cells were incubated on glass 
coverslips, which were coated with 2.5 µg/mL fibronectin, for 1 h at 37oC and 
subsequently fixed in either 4% paraformaldehyde with 4% glucose in PBS for 15 min at 
room temperature or methanol for 5 min on ice.  After fixation, cells were permeabilized 
by incubation with 0.2% (v/v) Triton X-100 for 3 min, and then blocked with 20% goat 
serum in PBS.  Following blocking, appropriate primary and second antibodies, diluted in 
5% goat serum with 0.2% Triton-X-100 in PBS, were added to the coverslips.  After each 
step, coverslips were rinsed three times with PBS. Coverslips were then mounted using 
Aqua Poly/Mount (Poly-sciences, Warrington, PA). Images were acquired using 
MetaMorph software and an Olympus PlanApo 60X OTIRFM objective (NA 1.45) 
(Melville, NY).  TIRF images were acquired by exciting with either a 488 or 543 nm laser 
line from a HeNe laser (Prairie Technologies, Middleton, WI).  For GFP and Alexa Fluor 
488, an Endow GFP Bandpass filter cube (excitation HQ470/40, emission HQ525/50, 
Q495LP dichroic mirror) (Chroma, Brattleboro, VT) was used. A TRITC/Cy3 cube 
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(excitation HQ545/30, emission HQ610/75, Q570LP dichroic mirror) was used for 
mCherry and Alexa Fluor 555.  An ET-CFP filter cube (excitation ET436/20, emission 
ET480/40, T455LP dichroic mirror) was used for CFP.  For TIRF imaging a z488/543 rpc 
filter was used. 
 For quantification of phosphorylated Akt (Thr308), the background subtracted, 
integrated fluorescence intensity from individual cells was measured and normalized to 
the unit area using MetaMorph software.  Phosphorylated Akt (Thr308) was quantified in 
adhesions by thresholding paxillin fluorescent staining, and creating an image mask of 
adhesions using the Integrated Morphometry Analysis package of MetaMorph. These 
masks were then applied to background subtracted, TIRF images of phosphorylated Akt, 
and the average level of active Akt in adhesions was quantified using the Integrated 
Morphometry Analysis package.  For this analysis, objects with an area less than 0.2 
m2 were excluded, because of the difficulty in distinguishing them from background 
puncta. 
 Sensitized Emission Image Processing: In order to calculate the CFP/FRET 
ratio image, it is necessary to go through a number of image processing steps. Typically, 
all of the images must first be corrected for any field non-uniformity in the sample 
excitation and for any background intensity within the images(Lacoste, Young et al. 
2012). In this case, the illumination field was very uniform because we used a confocal 
laser scanning microscope (CLSM) with a x63/1.4 NA Planapo oil immersion lens, and 
an image zoom factor of 2. Therefore, no correction was necessary. The background 
correction was done by measuring the average intensity of an ROI in the image where 
there are no cells and subtracting this intensity from each pixel grey value within the 
image. Correction factors for the CFP emission cross-talk and the Venus direct 
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excitation cross-talk were also calculated. Following this, the corrected FRET image 
(FRETCorr) can be calculated based on Equation 1 (Figure 10A). 
 Equation 1:                                   
Where FRETRaw is the original FRET image collected on the microscope (corrected for 
background and field non-uniformity (if necessary)). A is the percentage of Venus 
excitation cross-talk in the FRET image calculated from the control Venus sample. 
Venus is the corrected image of Venus expression in the sample following direct 
excitation by the 514 nm laser. B is the percentage of CFP emission cross-talk in the 
FRET channel calculated from the control CFP sample. CFP is the corrected image of 
the sample collected in the CFP channel. The ratio image is then calculated from 
Equation 2 (Figure 10B and C).  
 
 Equation 2:      
    
   
 
             
     (        )
 
        
     (   )
⁄  * 1000  
The numerator is essentially the normalized FRETCorr image and the denominator is the 
normalized CFP image. IMax is the maximum grey value in the FRETCorr (numerator) or 
CFP image (denominator). Images are based on integer values so the factor of 1000 is 
included to avoid fractional pixel intensities in the resultant ratio image.  
Sensitized Emission Image Analysis: HT1080 cells were plated on fibronectin-
coated glass coverslips for 1 h at 37oC and then fixed by incubation in 4% 
paraformaldehyde with 4% glucose in PBS for 15 min at room temperature. Images were 
acquired with a Zeiss 710 CLSM attached to an Axiobserver inverted.  The emission
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Figure 10: Calculation of FRET/CFP ratio images. (A) Background subtracted CFP, 
Venus and FRETRaw images (first 3 panels) are used with Equation 1 (where Venus is 
the Acceptor and CFP is the Donor) to create a FRETCorr image (far right panel).  (B) 
Upper panels, the newly created FRETCorr image and the CFP image from panel a are 
shown with a rainbow or pseudo-color coding look up table to emphasize subtle changes 
in intensity across the cells. These images are then normalized using the indicated 
equations to produce images with similar maximum intensity values (lower panels). (C) 
54 
 
The normalized images from panel b are then used to create a FRET/CFP ratio image 
by dividing the FRETCorr image by the CFP image and multiplying the result by 1000 (left 
panel). A median filter was used to reduce the image noise (right panel). Images are 
shown in pseudo-color coding. The scale bars are 10 μm. 
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settings on the Zeiss 710 microscope were set to collect the following wavelengths: CFP: 
454–568, Venus: 516–621 and RawFRET: 516-621.  For CFP and RawFRET, a 405 nm 
dichroic was used, and for Venus, a 458/514 nm dichroic was used. Background 
subtracted, FRET/CFP ratio images were generated using MetaMorph software. The 
equation used to calculate the FRET image for our experimental conditions was: FRET = 
RawFRET - 0.042 X Venus - 0.184 X CFP, where CFP is the image of CFP excited by 
the 405 nm laser, and Venus is the image of Venus excited directly by the 514 nm laser. 
The CFP and Venus correction factors (0.184 and 0.042, respectively) were calculated 
from cells expressing CFP or Venus fluorescent protein alone and imaged in the FRET 
channel under the same conditions as the RawFRET images (excited by the 405 nm 
laser).  The total FRET/CFP ratio was normalized to the unit area, and the average 
FRET/CFP ratio per cell was calculated.  Line scan analysis was performed using 
MetaMorph software with a line length of 5 µm and width of 1.32 µm, and the average 
FRET/CFP ratio was calculated as a function of distance from the cell edge.  FRET/CFP 
images shown were processed with a 3x3 median filter using MetaMorph software to 
reduce noise.  
Adhesion Turnover Assay: HT1080 cells were co-transfected with 1 µg 
mCherry-paxillin cDNA and 3 µg cDNA of the indicated constructs, plated on fibronectin-
coated microscopy dishes, and imaged as previously described (Bristow, Sellers et al. 
2009).  Briefly, fluorescent time-lapse images were obtained at 15 sec intervals, and the 
t1/2 values for adhesion assembly and disassembly were quantified (Webb, Donais et al. 
2004; Bristow, Sellers et al. 2009). 
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Results 
The signaling adaptor APPL1 inhibits cell migration: The multi-domain 
adaptor protein APPL1 (Figure 11A) has been shown to interact with various signaling 
and trafficking proteins, putting it in an ideal position to spatiotemporally coordinate 
signaling pathways that underlie processes such as cell migration.  This led us to 
hypothesize that APPL1 is an important regulator of migration. To begin to test our 
hypothesis, we expressed GFP and GFP-APPL1 in HT1080 cells, plated them on 
fibronectin, and assessed their migration using live-cell imaging.  The migration of 
individual cells was tracked using MetaMorph software, and Rose plots were generated 
from these data (Figure 11B).  The migration paths for GFP-APPL1 expressing cells 
were significantly shorter than those of control cells expressing GFP, suggesting that 
APPL1 decreased the rate of migration in HT1080 cells (Figure 11B).  Indeed, 
quantification of the migration speed revealed a 1.7-fold decrease in GFP-APPL1 
expressing cells compared with control cells expressing GFP (Figure 11B).  To further 
show a function for APPL1 in migration, we expressed GFP-APPL1 in MDA-MB-231 
cells, which have similar endogenous levels of APPL1 as HT1080 cells (Figure 12A).  As 
with HT1080 cells, expression of GFP-APPL1 significantly reduced the migration speed 
of MDA-MB-231 cells (Figure 12B).  Collectively, these results point to a role for APPL1 
in the regulation of cell migration. 
 We continued to probe the function of APPL1 in modulating migration by 
generating two small interfering RNA (siRNA) constructs to knock down endogenous 
expression of this protein. Although APPL1 siRNA 1 had been previously reported to be 
very effective (Miaczynska et al., 2004), we confirmed its ability to knock down 
expression of APPL1.  When wild-type HT1080 cells were transfected with APPL1 
siRNA 1, endogenous expression of APPL1 was decreased by over 80% compared to
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Figure 11.  APPL1 regulates cell migration.  (A) A schematic with the domain 
structure of APPL1 is shown.  (B) HT1080 cells were transfected with either GFP or 
GFP-APPL1, plated on fibronectin, and subjected to time-lapse microscopy.  Migration 
was quantified for individual cells, and Rose plots of migration tracks are shown (left 
panels).  Quantification of the migration speed for GFP and GFP-APPL1 expressing 
cells is shown (right panel). Error bars represent the S.E.M. for 49-64 cells from at least 
three separate experiments (*p<0.0001). (C) HT1080 cells were transfected with either 
empty pSUPER vector, a scrambled siRNA (Src siRNA) or APPL1 siRNA.  Cell lysates 
were subjected to immunoblot analysis to determine the levels of endogenous APPL1 
and β-actin (as a loading control) (left panel). Quantification of the endogenous levels of 
APPL1 in cells transfected with the indicated constructs is shown (right panel). Error 
bars represent the S.E.M. from four separate experiments (*p<0.0001, **p=0.0002). (D) 
Cells were transfected with empty pSUPER vector, a scrambled siRNA (Src siRNA) or 
APPL1 siRNA and used in migration assays three days later. Rose plots with migration 
tracks for cells transfected with the indicated constructs are shown (left panels).  
Quantification of the migration speed of cells transfected with the indicated constructs is 
shown (right panel). Error bars represent the S.E.M. for 46-64 cells from three individual 
experiments (*p<0.0009).  For panels C and D, asterisks indicate a statistically 
significant difference compared with pSUPER transfected cells.  
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Figure 12. APPL1 regulates cell migration in MDA-MB-231 cells. (A) HT1080 and 
MDA-MB-231 cell lysates were subjected to immunoblot analysis to determine the levels 
of endogenous APPL1 and β-actin (as a loading control). (B) MDA-MB-231 cells were 
transfected with either GFP or GFP-APPL1, plated on fibronectin, and subjected to time-
lapse microscopy. Quantification of the migration speed for GFP and GFP-APPL1 
expressing cells is shown. Error bars represent the S.E.M. for 33-57 cells from three 
separate experiments (*p=0.0032). 
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either empty pSUPER vector or a scrambled siRNA, as determined by western blot 
analysis (Figure 11C).  APPL1 siRNA 2 similarly decreased endogenous levels of 
APPL1 by approximately 65% compared to empty pSUPER vector or a scrambled 
siRNA (Figure 11C), indicating the APPL1 siRNAs were effective in knocking down 
expression of APPL1.   Transfection of HT1080 cells with APPL1 siRNA 1 and APPL1 
siRNA 2 led to a 1.4-fold and a 1.3-fold increase in migration speed, respectively, 
compared to pSUPER or scrambled siRNA transfected cells (Figure 11D). These results 
indicate that decreased expression of APPL1 enhances cell migration, thus implicating 
APPL1 as an important regulator of this process. 
Endosomal localization of APPL1 is required for its effects on migration: 
Since APPL1 localizes to early endosomes and signaling events that take place on 
endosomes are increasingly thought to play important roles in modeling cellular behavior 
(Miaczynska et al., 2004; von Zastrow and Sorkin, 2007), we hypothesized the APPL1 
localization to endosomes is critical for its ability to regulate cell migration.  To determine 
if APPL1 endosomal localization was necessary for its effects on migration, we mutated 
three basic residues (R147A, K153A and K155A) within the BAR domain of APPL1, 
which had previously been shown to be sufficient to disrupt its endosomal localization 
(Schenck et al., 2008).  GFP-APPL1, like endogenous APPL1, localized to vesicular 
structures; however, GFP-APPL1 that contained the point mutations (GFP-APPL1-AAA) 
no longer localized to endosomes when expressed in HT1080 cells (Figure 13, A and B).  
The migration speed of cells expressing GFP-APPL1-AAA was not significantly different 
from control GFP expressing cells (Figure 13, C and D).  These results suggest that the 
localization of APPL1 to endosomal membranes is critical for its ability to regulate cell 
migration.   
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Figure 13. APPL1 localizes to vesicular structures, which is critical in its 
regulation of cell migration.  (A) Wild-type HT1080 cells were immunostained for 
endogenous APPL1 (left panel) or transfected with either GFP-APPL1 (middle panel) or 
GFP-APPL1 in which three basic residues (147, 153, and 155) within the BAR domain 
were mutated to alanines (GFP-APPL1-AAA) (right panel).  Unlike GFP-APPL1 or the 
endogenous protein, GFP-APPL1-AAA did not localize to endosomal structures. Scale 
bar = 15 µm. (B) High magnification images of the boxed regions from panel A are 
shown. Scale bar = 15 m. (C) GFP and GFP-APPL1-AAA transfected cells were 
imaged using time-lapse microscopy and migration was analyzed.  Rose plots with 
migration tracks for these cells are shown.  (D) Quantification of the migration speed of 
GFP and GFP-APPL1-AAA expressing cells is shown. Error bars represent the S.E.M. 
for 52-66 cells from at least three separate experiments. 
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APPL1 regulates leading edge adhesion dynamics in migrating cells: 
Adhesion assembly and disassembly at the leading edge of cells, termed adhesion 
turnover, is required for efficient migration to occur (Webb et al., 2004; Nayal et al., 
2006).  This led us to hypothesize that APPL1 affects migration through its ability to 
regulate adhesion turnover.  To determine if APPL1 affects the number and/or size of 
adhesions, we expressed GFP and GFP-APPL1 in wild-type HT1080 cells and 
immunostained for endogenous paxillin, which is a well characterized adhesion marker.  
Cells expressing GFP-APPL1 exhibited a greater number of larger central adhesions 
and fewer nascent peripheral adhesions compared to control cells expressing GFP 
(Figure 14A).  In GFP-APPL1 expressing cells, the larger central adhesions could arise 
from their inability to efficiently turn over.  We examined this possibility by quantitatively 
measuring adhesion turnover using an assay that we previously developed (Webb et al., 
2004).  GFP and GFP-APPL1 expressing cells that were transfected with mCherry-
paxillin were subjected to time-lapse fluorescence microscopy, and the t1/2s for adhesion 
assembly and disassembly were assessed (Webb et al., 2004).  Cells expressing GFP-
APPL1 exhibited a 1.8-fold increase in the apparent t1/2 for adhesion assembly as 
compared to GFP controls (Figure 14, B and C), indicating that adhesions are forming 
considerably slower in the GFP-APPL1 expressing cells.  Moreover, GFP-APPL1 
expression led to a 1.4-fold increase in the t1/2 for adhesion disassembly (Figure 14, B 
and C).  
In addition, we used the adhesion turnover assay to examine the effects of GFP-
APPL1-AAA on adhesion dynamics. Cells expressing this mislocalization mutant had 
assembly and disassembly t1/2s of 2.1 ± 0.3 and 3.0 ± 0.3 min, respectively, which are 
not significantly different from those observed in GFP controls (Figure 14C). Taken
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Figure 14. APPL1 impairs adhesion turnover at the leading edge of cells. (A) Cells 
were transfected with either GFP or GFP-APPL1 and immunostained for the adhesion 
marker paxillin. Scale bar = 10 µm. (B) HT1080 cells were co-transfected with mCherry-
paxillin and either GFP or GFP-APPL1 and imaged using time-lapse microscopy.  In 
GFP-APPL1 expressing cells, the leading edge adhesions assemble and disassemble 
more slowly than those in control cells expressing GFP (arrows). Scale bar = 5 µm. (C) 
Quantification of the apparent t1/2 for adhesion assembly and the t1/2 for adhesion 
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disassembly for cells expressing the indicated constructs is shown. Error bars represent 
the S.E.M. for 26-30 adhesions from 4-6 cells from at least three independent 
experiments (*p<0.0001, **p≤0.007, ***p<0.013). Asterisks indicate a statistically 
significant difference compared with GFP cells. 
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together, these results demonstrate that APPL1 significantly slows the rate of adhesion 
assembly and disassembly in cells, in a manner dependent on its endosomal localization.   
 We further corroborated a role for APPL1 in modulating adhesion turnover by 
knocking down expression of the endogenous protein.  Expression of APPL1 siRNA 1 
and APPL1 siRNA 2 decreased the apparent t1/2 of adhesion assembly by 1.4-fold and 
1.5-fold, respectively, compared to both scrambled siRNA and GFP controls (Figure 
14C).  In addition, APPL1 siRNA 1 and APPL1 siRNA 2 decreased the t1/2 of adhesion 
disassembly by 1.7-fold and 1.8-fold, respectively, as compared to controls (Figure 14C). 
These results reveal that cells turn over their adhesions much faster when endogenous 
APPL1 expression is decreased, indicating an inhibitory role for APPL1 in the regulation 
of leading edge adhesion dynamics. 
APPL1 and Akt regulate cell migration and adhesion dynamics: Because Akt 
has been previously shown to interact with APPL1, and Akt has recently been implicated 
as a regulator of cell migration (Mitsuuchi et al., 1999; Kim et al., 2001; Arboleda et al., 
2003; Irie et al., 2005; Zhou et al., 2006; Ju et al., 2007; Schenck et al., 2008), APPL1 
may affect migration via a mechanism involving Akt.  Since the PTB domain of APPL1 
mediates its interaction with Akt (Mitsuuchi et al., 1999; Schenck et al., 2008), we 
expressed a GFP-APPL1 truncation mutant, which lacked the PTB domain (GFP-
APPL1-∆PTB), and assessed migration using time-lapse microscopy.  Expression of 
GFP-APPL1 significantly decreased the rate of migration compared with control GFP 
expressing cells (Figure 15, A and B).  However, the APPL1-induced decrease in 
migration was abolished in GFP-APPL1-∆PTB expressing cells, whose migration speed 
was similar to that observed in GFP control cells (Figure 15, A and B). This suggests 
that Akt contributes to the effect of APPL1 on cell migration. 
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Figure 15. Deletion of the PTB domain of APPL1 abolishes its effect on cell 
migration. (A) Cells transfected with GFP, GFP-APPL1, or GFP-APPL1-∆PTB were 
imaged using time-lapse microscopy and migration was analyzed. Rose plots of 
individual cell tracks are shown for each of the indicated constructs. (B) Quantification of 
the migration speed of cells transfected with the indicated constructs is shown.  Error 
bars represent the S.E.M. of 45-49 cells from at least three individual experiments 
(*p<0.0001). Asterisk indicates a statistically significant difference compared with GFP 
transfected cells. 
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We further investigated the relationship between APPL1 and Akt in the regulation 
of cell migration by using a mutant based approach.  We expressed either a dominant-
negative (DN-Akt) or a constitutively-active Akt1 mutant (CA-Akt) in wild-type HT1080 
cells and analyzed migration using time-lapse microscopy.  Cells expressing DN-Akt 
showed a 1.7-fold decrease in their speed of migration, as compared to control cells 
(Figure 16, A and B). In contrast, cells expressing CA-Akt exhibited a 1.3-fold increase in 
migration, as compared to controls (Figure 16, A and B). Interestingly, the migration 
speed of cells co-expressing either GFP-APPL1 and DN-Akt or GFP-APPL1 and CA-Akt 
did not significantly differ from cells expressing GFP-APPL1 alone (Figure 16, A and B). 
These results indicate GFP-APPL1 expression can suppress the CA-Akt-induced 
increase in migration, while it does not provide an additive effect on migration when co-
expressed with DN-Akt.  
To further investigate the ability of APPL1 to suppress Akt-induced migration, we 
generated stable HT1080 cells expressing either GFP or GFP-APPL1. In the stable 
GFP-APPL1 cells, the level of APPL1 expression was 1.5-fold over the endogenous 
protein (Figure 16C).  This expression level was comparable to that obtained with our 
transient transfections in which GFP-APPL1 was expressed at 1.9-fold over endogenous 
(Figure 16C). The GFP-APPL1 stable cells were then transfected with CA-Akt.  As with 
the transient transfections, expression of CA-Akt (3.1-fold over endogenous Akt, Figure 
16D) did not significantly affect the migration of GFP-APPL1 stable cells (Figure 16E). 
However, when the expression level of CA-Akt was increased to 5.3-fold over 
endogenous Akt (2X CA-Akt, Figure 16D), the migration speed of the GFP-APPL1 stable 
cells was increased (Figure 16E). These results indicate that while 
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Figure 16. Akt plays an important role in the APPL1-mediated regulation of cell 
migration.  (A) HT1080 cells were co-transfected with GFP or GFP-APPL1 and either 
empty vector, constitutively active Akt (CA-Akt), or dominant negative Akt (DN-Akt) and 
used in migration assays.  Rose plots with individual migration tracks for cells 
transfected with the indicated constructs are shown. (B) Quantification of the migration 
speed of cells transfected with the indicated constructs is shown. Error bars represent 
the S.E.M. of 35-65 cells from at least three individual experiments (*p<0.0001). (C) 
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Lysates from HT1080 cells transiently transfected with GFP-APPL1 (Transients) and 
HT1080 cells stably expressing GFP-APPL1 (Stables) were subjected to immunoblot 
analysis to determine the levels of total APPL1 (endogenous and exogenously 
expressed GFP-APPL1) (upper panels).  Quantification of the relative amounts of GFP-
APPL1 compared to endogenous APPL1 is shown (lower panel).  Error bars represent 
the S.E.M. from at least three separate experiments (*p<0.05). Asterisks indicate a 
statistically significant difference compared with endogenous APPL1.  (D) Stable 
HT1080 cells expressing GFP were transfected with empty vector (GFP).  Stable 
HT1080 cells expressing GFP-APPL1 were transfected with empty vector (GFP-APPL1), 
1.5 µg of CA-Akt cDNA (GFP-APPL1 + CA-Akt), or 3 µg of CA-Akt cDNA (GFP-APPL1 + 
2X CA-Akt). Cell lysates were subjected to immunoblot analysis to determine the levels 
of total Akt (endogenous and exogenously expressed CA-Akt) and β-actin (as a loading 
control) (left panel).  Quantification of the relative amount of Akt expression compared to 
that observed in control GFP cells is shown (right panel). Error bars represent the S.E.M. 
from three separate experiments (*p≤0.03). Asterisks indicate a statistically significant 
difference compared with control GFP cells. (E) Stable HT1080 GFP or GFP-APPL1 
cells were transfected as described in panel D and used in migration assays. 
Quantification of the migration speed of transfected cells is shown.  Error bars represent 
the S.E.M. of 80-91 cells from three individual experiments (*p<0.0001). Asterisks 
indicate a statistically significant difference compared with GFP cells. 
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GFP-APPL1 expression can inhibit low levels of CA-Akt from promoting migration, 
higher expression of CA-Akt can overcome this inhibition. 
 We next generated two siRNA constructs to knockdown endogenous Akt. 
Although we had previously used these two siRNA sequences to effectively knockdown 
endogenous Akt (Bristow et al., 2009), we confirmed their efficacy by transfecting them 
into HT1080 cells. Here, we obtained similar results, where Akt siRNA 1 knocked down 
endogenous Akt to 61.8 ± 9.4% of control levels, while Akt siRNA 2 had an efficacy of 
51.9 ± 4.7% (n= 4 separate experiments for each siRNA).  Migration was then analyzed 
to determine the effect of these constructs on this process. Cells transfected with Akt 
siRNA 1 exhibited a 1.5-fold decrease in migration speed compared to either empty 
pSUPER vector or scrambled siRNA expressing cells (Figure 17, A and B).   Similarly, 
Akt siRNA 2 transfected cells showed a 1.6-fold decrease in migration speed compared 
with controls (Figure 17, A and B).  Moreover, expression of GFP-APPL1 along with Akt 
knockdown showed no further effect on migration (Figure 17, A and B), which is 
consistent with the results obtained when GFP-APPL1 was co-expressed with DN-Akt 
(Figure 17, A and B).  Taken together, these results suggest that APPL1 is regulating 
cell migration by inhibiting Akt function. 
 Since our results indicated that the APPL1-Akt association is critical in the 
regulation of cell migration, we assessed the effect of APPL1 and Akt on adhesion 
turnover.  In cells expressing GFP-APPL1-∆PTB, the apparent t1/2 for adhesion 
assembly and the t1/2 for adhesion disassembly were similar to those obtained for GFP 
control cells, indicating that deletion of the PTB domain of APPL1 abolished its effect on 
adhesion turnover (Figure 14C).  We further probed the role of APPL1 and Akt in 
modulating adhesion dynamics by co-expressing Akt mutants with GFP or GFP-APPL1.  
Expression of CA-Akt decreased the t1/2 of adhesion assembly and disassembly, as 
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Figure 17. Akt knockdown inhibits cell migration. (A) HT1080 cells were co-
transfected with empty pSUPER vector, a scrambled siRNA (Scr siRNA), or Akt siRNA 
and either GFP or GFP-APPL1, and imaged using time-lapse microscopy three days 
later. Rose plots are shown for the migration tracks of cells expressing the indicated 
constructs. (B) Quantification of the migration speed of cells transfected with the 
indicated constructs is shown. Error bars represent the S.E.M. of 56-76 cells from three 
separate experiments (*p<0.0001). 
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compared to GFP control cells, while DN-Akt expression led to a significant increase in 
the t1/2 values (Figure 14C).  When GFP-APPL1 was co-expressed with the Akt mutants, 
the t1/2s were not significantly different from those observed in cells expressing GFP-
APPL1 alone (Figure 14C). Thus, as with migration, APPL1 inhibits the function of CA-
Akt in regulating adhesion turnover, while providing no additional effect on adhesion 
dynamics when co-expressed with DN-Akt.   
APPL1 reduces the amount of active Akt in cells: To begin to elucidate the 
mechanism by which the APPL1-Akt association regulates migration and adhesion 
dynamics, we examined the effect of APPL1 on the level of active Akt.  Canonically, Akt 
is activated through phosphorylation on two amino acids, Thr308 and Ser473 (Alessi et 
al., 1996), and thus, phosphorylation-specific antibodies against these residues can be 
used to detect active Akt.  Cells expressing GFP and GFP-APPL1 were immunostained 
with phospho-Thr308-Akt antibody and imaged using fluorescence microscopy. The 
fluorescent intensity of active Akt was then quantified for individual cells using 
MetaMorph software. Expression of GFP-APPL1 reduced the level of active Akt by 
approximately 2-fold as compared to control cells expressing GFP (Figure 18A).  
Knockdown of endogenous APPL1 using APPL1 siRNA 1 and APPL1 siRNA 2 
increased the amount of active Akt by almost 1.5-fold compared to empty pSUPER 
vector, while scrambled siRNA had no significant effect on the level of active Akt (Figure 
18B).  Interestingly, the GFP-APPL1-∆PTB mutant did not significantly affect the amount 
of active Akt in HT1080 cells (101.7 ± 3.3% of control, n=85 cells), suggesting that an 
association between APPL1 and Akt is necessary for the APPL1 effect on active Akt.  
Moreover, the level of active Akt in GFP-APPL1-AAA expressing cells was similar to that 
observed in GFP control cells (95.2 ± 3.4% of control, n=145 cells), indicating APPL1 
regulates the amount of active Akt in cells in a manner dependent on its 
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Figure 18. APPL1 reduces the amount of active Akt in cells. (A) HT1080 cells were 
transfected with either GFP or GFP-APPL1, fixed, and immunostained for active Akt 
using a phospho-Thr308 specific antibody.  Quantification of the fluorescent intensity in 
transfected cells is shown.  The background subtracted, integrated fluorescent intensity 
was normalized to cell area (average intensity). Error bars represent the S.E.M. from 
greater than 150 cells from at least six individual experiments (*p<0.0001). (B) HT1080 
cells were transfected with empty pSUPER vector, scrambled siRNA (Scr siRNA), 
APPL1 siRNA 1, or APPL1 siRNA 2 and immunostained for active Akt three days later.  
Quantification of the fluorescent intensity in transfected cells is shown.  Error bars 
represent the S.E.M. of 78-121 cells from three separate experiments (*p<0.0001). 
Asterisks denote a statistically significant difference compared with pSUPER transfected 
cells. 
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endosomal localization.  Collectively, these results indicate that APPL1 regulates the 
amount of active Akt in cells and point to an important role for this function of APPL1 in 
modulating cell migration.   
 We used a previously described Akind fluorescence resonance energy transfer 
(FRET) probe (Yoshizaki et al., 2007) to further investigate the role of APPL1 in 
regulating Akt activity.  Akind is composed of the Akt PH domain (amino acids 1-144), 
the fluorescent protein Venus, the Akt catalytic and regulatory domains (amino acids 
133-480), and cyan fluorescent protein (CFP) (Yoshizaki et al., 2007). Upon activation, 
Akind undergoes a conformational change that brings Venus and CFP into close enough 
proximity to undergo FRET (Figure 19).  In order to determine if Akind was being 
properly activated in HT1080 cells, we compared Akt activity of the wild-type Akind 
probe with a non-activatable Akind mutant in which 3 key residues (K179, T308, and 
S473) have been mutated to alanine (3A-Akind). Results from using the Wt-Akind probe 
show a significantly higher intensity in the FRET/CFP ratio image compared to the 
dominant negative 3A-Akind probe (Figure 20A). Quantification of the results shows that 
there is an approximately 3-fold increase in the FRET/CFP ratio for Akind relative to the 
dominant negative 3A-Akind (Figure 20B). Therefore, Akind is being properly activated in 
HT1080 cells. 
Next, we assessed the effects of APPL1 on Akt activation by expressing the 
Akind FRET probe with either mCherry-APPL1 or mCherry (as a control). Cells 
expressing mCherry-APPL1 exhibited a 1.8-fold decrease in the average Akind 
FRET/CFP ratio, when compared to mCherry expressing control cells (Figure 21A).
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Figure 19: Schematic diagram of the Akt activation CFP-Venus FRET probe 
(Akind). This figure was designed based on Figure 1 from Yoshizaki et al. Molecular 
Biology of the Cell 18:119-128 (2007). Akind consists of an Akt pleckstrin (PH) homology 
domain, followed by Venus fluorescent protein, an Akt catalytic domain (CD) and finally 
CFP. a) In its basal state, there is minimal FRET, as the CFP and Venus fluorophores 
are not within 10 nm of one another. Thus, if CFP is excited, cyan fluorescence will be 
emitted. b) When Akind is recruited to the plasma membrane via an interaction between 
its PH domain and PIP3, it is activated by two phosphorylation events (P). These 
phosphorylation events cause a conformational change in the Akind probe, bringing the 
CFP and Venus fluorophores within close enough proximity to allow FRET to occur. 
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Figure 20: Comparison of the FRET ratio images for wild-type and mutant Akind 
probes. (A) Representative FRET/CFP ratio images collected with a x63/1.4 NA 
objective lens for HT1080 cells expressing either wild-type (Wt) Akind or a non-
activatable Akind mutant in which 3 key residues have been mutated to alanine (3A-
Akind) are shown. Scale bar is 10 µm. (B) Quantification of the average FRET/CFP ratio 
in HT-1080 cells expressing either Wt-Akind or 3A-Akind is shown. Error bars represent 
the S.E.M for at least 7 cells (p= 0.035). The asterisk indicates a statistically significant 
difference compared with Wt-Akind.  
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Figure 21.  APPL1 decreases Akt activity in cells. (A) HT1080 cells were co-
transfected with either mCherry or mCherry-APPL1 and the Akt activity FRET probe 
Akind. Ratio images of FRET/CFP are shown in pseudo-color coding (left panels). Scale 
bar = 10 µm.  Quantification of the average FRET/CFP ratio for cells co-transfected with 
either mCherry or mCherry-APPL1 and Akind is shown (right panel). Error bars 
represent the S.E.M. from greater than 34 cells from at least three individual 
experiments (*p<0.0001). (B) HT1080 cells were co-transfected with either mCherry or 
mCherry-APPL1 and Akind. Ratio images of FRET/CFP at the cell edge are shown in 
pseudo-color coding (left panels).  Scale bar = 5 µm.  A line scan analysis was 
performed on the boxed region, which represents an area 5 µm long and 1.3 µm wide. 
Quantification of the line scan analysis is shown (right panel).  Error bars represent the 
S.E.M. of 52-59 total line scans from 20 cells from three separate experiments. 
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When we quantified Akt activity as a function of distance from the edge of cells, the 
FRET/CFP ratio in control cells was high at the cell edge (Figure 21B), indicating active 
Akt was localized to this region.  In mCherry-APPL1 expressing cells, the FRET/CFP 
ratio was decreased 2.9-fold at the cell edge compared with controls (Figure 21B).  Akt 
activity was also decreased 2.2-fold at a distance of 5 m behind the cell edge in 
mCherry-APPL1 expressing cells (Figure 21B).  Taken together, these results indicate 
that APPL1 decreases the amount of active Akt in cells, and a significant reduction of 
Akt activity is seen at the cell edge. 
 Since APPL1 affected the level of active Akt at the cell edge, and APPL1 and Akt 
modulated the turnover of adhesions at the leading edge, we hypothesized that APPL1 
regulates the amount of active Akt in adhesions.  We addressed this by co-
immunostaining control and APPL1 expressing cells for active Akt, using the phospho-
Thr308-Akt antibody, and paxillin.  Individual paxillin-containing adhesions were 
visualized using total internal reflection fluorescence (TIRF) microscopy, and the levels 
of active Akt were quantified in these adhesions.  The amount of active Akt in adhesions 
in APPL1 expressing cells was decreased 1.7-fold as compared to that observed in 
control cells (Figure 22, A and B).  This result suggests that APPL1 regulates cell 
migration and adhesion turnover by reducing the amount of active Akt in adhesions. 
APPL1 regulates the tyrosine phosphorylation of Akt by Src: Since tyrosine 
phosphorylation of Akt by Src has recently been shown to be important in both the 
activation of Akt as well as its biological function (Chen et al., 2001; Choudhury et al., 
2006; Bouchard et al., 2007), we hypothesized that Src-mediated tyrosine 
phosphorylation of Akt was critical for its effects on migration.  We began to test this 
hypothesis by assessing tyrosine phosphorylation of Akt by Src in HT1080 cells.  Wild-
type HT1080 cells were transfected with FLAG-Akt and subsequently treated with
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Figure 22. APPL1 reduces the amount of active Akt in adhesions. (A) HT1080 cells 
were transfected with CFP and either empty vector (Control) or FLAG-APPL1 (APPL1), 
fixed, and immunostained for active Akt, using a phospho-Thr308-specific antibody (P-
Akt), and paxillin. TIRF images of paxillin (left panels) and P-Akt (middle panels) are 
shown.  P-Akt images are shown in pseudo-color coding that indicates the range of 
fluorescent intensities to the assigned color (P-Akt, right panels).  Overlays of paxillin 
and P-Akt are shown (far right panels). Scale bar = 2 µm. (B) Quantification of phospho-
Thr308 Akt levels in adhesions in cells transfected with the constructs from panel A is 
shown.  Error bars represent the S.E.M. of greater than 4782 adhesions from 58-63 cells 
from three separate experiments (*p=0.0251). 
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various concentrations of the Src family kinase inhibitor PP2.  Treatment with 1 M PP2 
decreased Akt tyrosine phosphorylation by 1.8-fold compared to DMSO controls, while 
7.5 M PP2 decreased the levels of tyrosine phosphorylation by 4.6 fold (Figure 23A). 
To further support a role for Src in Akt tyrosine phosphorylation, we transfected HT1080 
cells with constitutively-active Src (CA-Src).  Expression of CA-Src resulted in a 10-fold 
increase in the amount of Akt tyrosine phosphorylation compared to controls (Figure 
23B), suggesting a critical role for Src in mediating Akt tyrosine phosphorylation. 
 We next assessed the ability of APPL1 to regulate Akt tyrosine phosphorylation. 
When APPL1 was co-expressed with FLAG-Akt in HT1080 cells, tyrosine 
phosphorylation of Akt was decreased 1.9-fold compared to control cells (Figure 23C). 
Moreover, expression of APPL1 with CA-Src reduced Akt tyrosine phosphorylation by 
2.4-fold (Figure 23D). Collectively, these data point to an important new function for 
APPL1 in regulating the Src-mediated tyrosine phosphorylation of Akt.  
Src-mediated tyrosine phosphorylation of Akt is critical for its activation 
and function: Since our data indicated that APPL1 regulates the amount of active Akt in 
cells, we thought it may be through a mechanism that involves Src and the tyrosine 
phosphorylation of Akt.  In initial experiments, we assessed the ability of APPL1 and Src 
to regulate Akt T308 phosphorylation.  Expression of APPL1 led to a 1.5-fold reduction in 
Akt T308 phosphorylation as compared to control cells, which confirmed our previous 
experiments showing that APPL1 decreases the amount of active Akt (Figure 24A). We 
next examined the effects of Src activity on Akt T308 phosphorylation. Expression of CA-
Src resulted in a 4-fold increase in Akt T308 phosphorylation (Figure 24A).  However, 
when APPL1 was co-expressed with CA-Src in HT1080 cells, Akt T308 phosphorylation 
was decreased significantly compared to that observed in cells expressing CA-Src
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Figure 23.  Src mediates tyrosine phosphorylation of Akt. (A) FLAG-Akt transfected 
HT1080 cells were incubated with the indicated concentrations of PP2 for 1.5 h. FLAG-
Akt protein was immunoprecipitated from cell lysates, and FLAG-Akt samples were 
subjected to immunoblot analysis to determine the levels of total FLAG-Akt, using FLAG 
M2 antibody (FLAG), and tyrosine phosphorylated Akt with 4G10 monoclonal antibody 
(4G10) (left panels). Quantification of the amount of Akt tyrosine phosphorylation is 
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shown relative to the Control (0 µM PP2) (right panel).  Error bars represent the S.E.M. 
from three separate experiments (*p≤0.0031). (B) HT1080 cells were co-transfected with 
FLAG-Akt and either GFP (Control) or GFP-CA-Src. Immunoprecipitated FLAG-Akt 
protein samples were immunoblotted for total FLAG-Akt (FLAG) and tyrosine 
phosphorylated Akt (4G10) (left panels). Quantification of the relative amount of Akt 
tyrosine phosphorylation compared to Control is shown (right panel).  Error bars 
represent the S.E.M. from three separate experiments (*p=0.025). (C) FLAG-Akt was 
immunoprecipitated from lysates of cells expressing FLAG-Akt and either GFP (Control) 
or GFP-APPL1 (APPL1). Samples were subjected to immunoblot analysis to determine 
the levels of total FLAG-Akt (FLAG) and tyrosine phosphorylated Akt (4G10) (left panels). 
Quantification of the relative amount of Akt tyrosine phosphorylation compared to 
Control is shown (right panel).  Error bars represent the S.E.M. from three separate 
experiments (*p≤0.0001). (D) HT1080 cells were co-transfected with FLAG-Akt and 
either mCherry + GFP-CA-Src (CA-Src) or mCherry-APPL1 + GFP-CA-Src (CA-Src + 
APPL1). Immunoprecipitated FLAG-Akt protein samples were subjected to immunoblot 
analysis to determine the levels of total FLAG-Akt (FLAG) and tyrosine phosphorylated 
Akt (4G10) (left panels). Quantification of the relative amount of Akt tyrosine 
phosphorylation compared that observed in Control cells from panel B is shown (right 
panel).  Error bars represent the S.E.M. from three separate experiments (*p=0.048).  
Asterisk indicates a statistically significant difference compared with CA-Src transfected 
cells. 
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Figure 24. Tyrosine phosphorylation of Akt regulates its activation and function. 
(A) HT1080 cells were co-transfected with FLAG-Akt and either mCherry + GFP 
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(Control), mCherry-APPL1 + GFP (APPL1), mCherry + GFP-CA-Src (CA-Src), or 
mCherry-APPL1 + GFP-CA-Src (CA-Src + APPL1). After 24 h, FLAG-Akt was 
immunoprecipitated from cell lysates and subjected to immunoblot analysis to determine 
the levels of total FLAG-Akt (FLAG) and T308 phosphorylated Akt (T308) (left panels). 
Quantification of the relative amount of T308 phosphorylated Akt compared to Control is 
shown (right panel).  Error bars represent the S.E.M. from at least ten separate 
experiments (*p<0.0001, **p≤0.002, ***p=0.031). (B) HT1080 cells were transfected with 
FLAG-Akt (Wt-Akt) or FLAG-Akt-Y315F/Y326F (Akt-Y315F/Y326F). Immunoprecipitated 
FLAG-Akt protein was subjected to immunoblot analysis to determine the levels of total 
FLAG-Akt (FLAG) and tyrosine phosphorylated Akt (4G10) (upper panels). 
Quantification of the relative amount of Akt tyrosine phosphorylation compared to Wt-Akt 
is shown (lower panel).  Error bars represent the S.E.M. from four separate experiments 
(*p<0.0001). (C) HT1080 cells were transfected with GFP-CA-Src (CA-Src) and either 
FLAG-Akt (Wt-Akt) or FLAG-Akt-Y315F/Y326F (Akt-Y315F/Y326F).  After 24 h, FLAG-
Akt protein was immunoprecipitated from cell lysates, and samples were subjected to 
immunoblot analysis to determine the levels of total FLAG-Akt (FLAG) and tyrosine 
phosphorylated Akt (4G10) (upper panels). Quantification of the relative amount of Akt 
tyrosine phosphorylation compared to that observed in cells transfected with Wt-Akt + 
CA-Src is shown (lower panel).  Error bars represent the S.E.M. from three separate 
experiments (*p<0.0001). (D) HT1080 cells were co-transfected with GFP and either 
empty vector (Control), constitutively active Akt (CA-Akt), or CA-Akt-Y315F/Y326F and 
used in migration assays. Rose plots with migration tracks for these cells are shown (left 
panels).  Quantification of the migration speed for cells transfected with the indicated 
constructs is shown (right panel). Error bars represent the S.E.M. for at least 56 cells 
from at least three separate experiments (*p<0.0001, **p=0.0019). 
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(Figure 24A).  Thus, these results suggest APPL1 reduces the amount of active Akt in 
cells by inhibiting tyrosine phosphorylation of Akt by Src. Since previous work had shown 
that the major Src phosphorylation sites in Akt, which are important in regulating its 
activity and function, are tyrosines 315 and 326 (Chen et al., 2001), we mutated these 
tyrosine residues to phenylalanines. In cells expressing the Akt tyrosine mutant (Akt-
Y315F/Y326F), a 1.6-fold decrease in tyrosine phosphorylation was observed compared 
to that seen in wild-type Akt (Wt-Akt) expressing cells (Figure 24B).  In addition, the CA-
Src-mediated increase in Akt tyrosine phosphorylation was reduced by 1.7-fold in cells 
expressing Akt-Y315F/Y326F compared to Wt-Akt expressing cells (Figure 24C).  These 
results suggest that residues 315 and 326 are major targets of phosphorylation by Src.  
 Next, we assessed the importance of phosphorylation at tyrosines 315 and 326 
in regulating Akt-mediated migration. Consistent with our previous data, expression of 
CA-Akt in HT1080 cells promoted a 1.2-fold increase in the migration speed compared 
to controls (Figure 24D).  In contrast, mutation of tyrosines 315 and 326 in CA-Akt 
significantly reduced the migration of HT1080 cells.  The migration speed of cells 
expressing CA-Akt-Y315F/Y326F was decreased 1.5-fold compared to that observed in 
control cells (Figure 24D).  Taken together, these results indicate that tyrosine 
phosphorylation by Src is a critical regulator of Akt-mediated cell migration, and APPL1 
inhibits migration by decreasing this tyrosine phosphorylation.  
Discussion 
While the signaling adaptor APPL1 has been implicated in the modulation of 
various cellular processes, such as proliferation and survival (Liu et al., 2002; Schenck 
et al., 2008), its role in controlling cell migration is not well understood.  Here we show 
that APPL1 impairs the migration of HT1080 cells by regulating the assembly and 
disassembly of leading edge adhesions.  APPL1 modulates migration and adhesion 
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dynamics through a molecular mechanism that is dependent on the Src-mediated 
tyrosine phosphorylation of Akt.  Interestingly, APPL1 was recently shown to affect the 
ability of murine embryonic fibroblasts (MEFs) to migrate in response to HGF (Tan et al., 
2010), which is consistent with our data indicating that it is an important modulator of this 
process.  Intriguingly, this study found that APPL1 was dispensable for the survival of 
MEFs, at least under normal culture conditions (Tan et al., 2010).   
Our results indicate that APPL1 regulates cell migration through its multi- 
functional domains, which mediate its interaction with other proteins as well as lipids.  
When the PTB domain of APPL1 is deleted, it is unable to inhibit migration in HT1080 
cells.  This region of APPL1 has been previously shown to be important in its binding to 
Akt (Mitsuuchi et al., 1999), suggesting APPL1 modulates migration through Akt. 
Nevertheless, we cannot rule out contributions from other APPL1 interacting proteins, 
since the tumor suppressor DCC, human follicle-stimulating hormone receptor, the 
neurotrophin receptor TrkA, and the TrkA-interacting protein GIPC1 have also been 
shown to bind to this region of APPL1 (Liu et al., 2002; Nechamen et al., 2004; Lin et al., 
2006).  However, we provide additional results that strongly demonstrate APPL1 
regulates migration by modulating Akt activity and function. 
We show that Akt is a positive regulator of migration in HT1080 cells, where CA-
Akt increases migration speed, while DN-Akt and knockdown of endogenous Akt both 
decrease migration. When APPL1 is exogenously expressed with CA-Akt (3-fold over 
endogenous), it abolishes the CA-Akt-promoted increase in migration, indicating that 
APPL1 inhibits Akt function.  In contrast, increasing the amount of CA-Akt (5-fold over 
endogenous) negates this effect of APPL1, demonstrating higher expression of CA-Akt 
can overcome this inhibition by APPL1.   When APPL1 is co-expressed with either DN-
Akt or in Akt knockdown cells, no further decrease in migration is observed, suggesting 
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APPL1 and Akt are in the same signaling pathway that regulates migration.  This role of 
Akt in promoting cell migration is consistent with previous studies (Kim et al., 2001; Irie 
et al., 2005; Ju et al., 2007; Bristow et al., 2009).  Interestingly, some previous studies 
looking at the relationship between APPL1 and Akt have shown APPL1 to be a positive 
regulator of Akt activation (Nechamen et al., 2004; Lin et al., 2006; Saito et al., 2007; 
Cheng et al., 2009; Wen et al., 2010), whereas our results indicate APPL1 decreases 
the amount of active Akt.  This discrepancy may be, at least in part, due to the isoform of 
Akt being observed. The major isoform of Akt in HT1080 cells is Akt1 (Figure 25), while 
most of the previous work was focused on Insulin/Akt2 signaling or on signaling in the 
nervous system where Akt3 is the major isoform.  Indeed, recent work has shown that 
APPL1 inhibits Akt1 activity (Bohdanowicz et al., 2011; Tu et al., 2011).  
Several residues (147, 153 and 155) within the BAR domain of APPL1 are 
essential for its ability to regulate cell migration. The BAR domain of APPL1 is 
structurally unique in that it interacts with the PH domain to form a functional unit (Li et 
al., 2007; Zhu et al., 2007).  This integrated functional dimer interacts with the 
endosomal protein Rab5 and is responsible for APPL1’s endosomal localization 
(Miaczynska et al., 2004; Li et al., 2007; Zhu et al., 2007).  The endosomal localization is 
important for APPL1 to regulate Akt substrate specificity (Schenck et al., 2008), 
suggesting that APPL1 signaling on endosomes is critical to its function.   Indeed, our 
results indicate that APPL1 localization to endosomal membranes is critical for its ability 
to regulate cell migration through Src and Akt.  Akt activation, which is typically thought 
to occur at the plasma membrane, has also been shown to take place on signaling 
endosomes (Wang et al., 2002).  In this context, APPL1 may function as a scaffold for 
bringing signaling proteins to endosomal structures, which can be targeted to specific 
regions within the cell in a spatiotemporal manner. 
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Figure 25. Akt1 is the major Akt isoform in HT1080 cells. Lysates from HT1080 cells 
were subjected to immunoblot analysis to determine the expression levels of the 
indicated Akt isoforms and β-actin (as a loading control). 
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 While several adaptor proteins have recently been reported to regulate 
processes underlying migration, namely adhesion dynamics (Nayal et al., 2006; Zaidel-
Bar et al., 2007; Kanchanawong et al., 2010), the importance of APPL1 in contributing to 
this process is unknown.  We show that APPL1 is a negative regulator of adhesion 
turnover where exogenous expression of APPL1 increases the apparent t1/2 for adhesion 
assembly as well as the t1/2 for adhesion disassembly.  Knockdown of endogenous 
APPL1 has the opposite effect on adhesion turnover. This phenotype is dependent on 
the PTB domain of APPL1, as expression of the APPL1-∆PTB mutant has no effect on 
adhesion turnover. The dependence on the PTB domain suggests that Akt contributes to 
the APPL1-mediated regulation of adhesion turnover.  Indeed, we have previously 
demonstrated a potential role for Akt in regulating adhesion dynamics (Bristow et al., 
2009) and show here that expression of CA-Akt stimulates more rapid adhesion turnover, 
while DN-Akt induces slower turnover. Co-expression of exogenous APPL1 with CA-Akt 
negates the CA-Akt-promoted increase in adhesion turnover, while co-expression with 
DN-Akt has no additional effect.  Moreover, expression of APPL1 causes a decrease in 
the amount of active Akt at the cell edge as well as in adhesions. Thus, APPL1 may 
regulate the assembly and disassembly of adhesions at the leading edge by inhibiting 
Akt function.  This would lead to impaired turnover of leading edge adhesions, which 
could significantly slow cell migration. 
Phosphorylation at threonine 308 and serine 473 has classically been thought to 
activate Akt (Alessi et al., 1996).  However, more recent work indicates that Akt activity 
is also regulated by tyrosine phosphorylation, which is carried out by Src (Chen et al., 
2001). In our study, inhibition of Src with PP2 led to a decrease in the tyrosine 
phosphorylation of Akt, while promotion of Src activity, through expression of CA-Src, 
increased the level of tyrosine phosphorylated Akt, indicating that Src can tyrosine 
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phosphorylate Akt.  In addition, APPL1 decreased tyrosine phosphorylation of Akt and 
inhibited the CA-Src-promoted increase in Akt tyrosine phosphorylation.  These 
alterations in tyrosine phosphorylation are accompanied by corresponding changes in 
T308 phosphorylation of Akt, which has not been previously shown.  Moreover, mutation 
of two previously described Src phosphorylation targets (tyrosines 315 and 326) (Chen 
et al., 2001) to phenylalanines in CA-Akt reduced migration similarly to that observed 
with co-expression of APPL1 with CA-Akt.  Thus, APPL1 can inhibit Akt function by 
reducing the tyrosine phosphorylation of Akt by Src, which hinders cell migration.   
Our results support a working model in which the adaptor protein APPL1 inhibits 
cell migration and adhesion dynamics through a mechanism involving the Src-mediated 
tyrosine phosphorylation of Akt.  Tyrosine phosphorylation of Akt by Src enhances the 
activity of Akt.  APPL1, in turn, decreases the amount of active Akt in adhesions and at 
the cell edge by reducing Akt tyrosine phosphorylation.  This leads to an inhibition of Akt 
function particularly within regions of cells where Akt activity is high, such as the cell 
edge and adhesions.  As a result, the ability of cells to turn over their adhesions is 
diminished, which leads to an impairment of cell migration.   
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Chapter IV 
 
CONCLUSIONS AND FUTURE DIRECTIONS 
 
  
Cell migration is a complex process that requires highly coordinated, 
spatiotemporally regulated signaling networks. Many of the major signaling molecules 
(for example, kinases and phosphatases) are ubiquitously expressed, and yet they can 
have cell-type and tissue-specific effects. One of the prevailing ideas as to how this 
occurs is that other molecules in the cell’s protein milieu are able to differentially regulate 
these signaling hubs. For example, adaptor proteins are able to localize signaling to 
specific regions of cells, through the use of their multiple domains. They are able to bring 
signaling components together as well as localize them to subcellular domains (for 
example, the leading edge of a migrating cell) through interactions with other proteins as 
well as lipids. In this way, they are strong candidates for modulating highly complex, 
spatiotemporally regulated processes, such as cell migration. 
Here, for the first time, we have generated a comprehensive phosphorylation 
map of the adaptor protein APPL1. We identified a total of 13 phosphorylated residues 
within APPL1 using mass spectrometry. Interestingly, four of these 13 phosphorylated 
residues are located within functional domains of APPL1, one within the BAR domain, 
two near the edge of the PH domain, and one within the PTB domain (Tables 1-2 and 
Figures 6-7). These represent key potential targets for regulation of APPL1 function. We 
expect that mutation of these phosphorylated residues, using site directed mutagenesis, 
would lead to alterations in APPL1 function. For example, one of these potential sites, 
serine 97/98, lies on the concave surface of the BAR domain (Figure 7). This domain is 
essential in APPL1 dimerization and localization (Zhu, Chen et al. 2007; Chial, Lenart et 
al. 2010).  We will use site directed mutagenesis to determine the effects of both a non-
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phosphorylatable (serinealanine) and a phosphomimetic (serineaspartic acid) 
mutation on the localization of a GFP-tagged APPL1. We expect that phosphorylation 
would lead to a dissociation of APPL1 from the membrane, as it is placing a bulky 
charged group between the APPL1-BAR domain’s concave surface and the lipid 
membrane. Therefore, we would expect the phosphomimetic mutant to no longer 
properly localize to membrane structure, while the non-phosphorylatable APPL1 would 
have no change or exhibit an increase in membrane localization. Moreover, serine 374 
lies within the PH domain and is in an area important for APPL1 interaction with the 
small GTPase Rab5 (Zhu, Chen et al. 2007). Therefore, phosphorylation at this site may 
regulate the interaction of APPL1 and Rab5, and represents an interesting area for 
future studies. Finally, we have identified serine 427 as a putative substrate of Akt 
(Tables 4 and 5). This site is located near the APPL1 PTB domain (Figure 6), which is 
the domain responsible for APPL1 and Akt interaction (Mitsuuchi, Johnson et al. 1999). 
Therefore, Akt may regulate APPL1 by binding and phosphorylating APPL1 at this site. 
Future studies, using site directed mutagenesis of this site, may lead to important 
insights as to how APPL1 and Akt interact to regulate cell migration and adhesion 
turnover. 
Here, we show a novel role for the adaptor protein APPL1 as a regulator of cell 
migration and adhesion turnover through its ability to modulate Akt activation and 
function. Expression of APPL1 in HT1080 cells decreases the average speed of cell 
migration. The ability of cells to both assemble and disassemble their adhesions 
(adhesion turnover) at the leading edge is critical for efficient migration to occur (Webb, 
Parsons et al. 2002). Interestingly, APPL1 expression leads to an increase in the t1/2 
values of adhesion assembly and disassembly, indicating APPL1 functions to slow 
adhesion turnover. It will be interesting to determine if other important aspects of cell 
migration are also altered by APPL1, for example alterations of leading edge protrusion 
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and actin dynamics, or changes in cell rear detachment. These all represent potential 
areas of future study. For instance, we will look at leading edge protrusion dynamics 
using live cell imaging coupled with kymography to observe extension and retraction 
rates of GFP-APPL1 expressing and control cells. 
APPL1 was first identified as an Akt binding partner. Akt has previously been 
shown to regulate cell migration. Therefore, we hypothesized APPL1 may regulate 
migration through Akt. Expression of CA-Akt leads to an increase in the average speed 
of HT1080 cells, while expression of DN-Akt has the opposite effect. Interestingly, 
APPL1 is able to suppress CA-Akt-promoted migration, while it has no additive effect 
with DN-Akt, suggesting these two proteins are in the same pathway that regulates 
migration. Moreover, analysis of adhesion turnover was used here to show CA-Akt leads 
to more rapid adhesion turnover, and APPL1 can abolish this effect. Also, DN-Akt leads 
to less rapid adhesion turnover, and APPL1 has no additive effects on DN-Akt 
suppressed adhesion turnover. These results are consistent with APPL1 reducing cell 
migration and adhesion turnover by inhibiting Akt function. 
The effects of APPL1 on Akt2 signaling, especially in the context of insulin 
signaling, is relatively well characterized compared to the effects of APPL1 on the other 
isoforms of Akt (Akt1 and Akt3). It is well established that APPL1 functions to increase 
Akt2 activation (Cheng, Iglesias et al. 2009; Deepa and Dong 2009). Therefore, when 
we first discovered that APPL1 reduced the amount of active Akt in HT1080 cells, we 
were slightly puzzled. However, we soon discovered that the major isoform of Akt 
present in these cells is Akt1, and there is little to no Akt2 or Akt3 (Figure 25). In addition, 
others have recently shown that indeed there is an Akt isoform specific effect of APPL1, 
where APPL1 reduces active Akt1 (Tan, You et al. 2010; Bohdanowicz, Balkin et al. 
2012). This is quite exciting, as the role of Akt in migration seems to have some isoform 
specificity (Stambolic and Woodgett 2006). It would be interesting to determine if these 
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disparities could be explained by differential regulation of Akt1 and Akt2 by APPL1, and 
provides a very attractive avenue of future study, as there are also distinct effects of 
Akt1 and Akt2 on tumor invasion and metastasis (Irie, Pearline et al. 2005; Maroulakou, 
Oemler et al. 2007). Moreover, there is little known about the effects of Akt isoform 
specificity on adhesion turnover. 
In addition to phosphorylation of threonine 308 and serine 473, tyrosine 
phosphorylation has also been shown to regulate Akt activation and function (Chen, Kim 
et al. 2001; Choudhury, Mahimainathan et al. 2006). This phosphorylation is mediated 
by Src. Here, we show that APPL1 can inhibit Src-mediated tyrosine phosphorylation of 
Akt. Moreover, we have identified a novel role of Akt tyrosine phosphorylation in 
mediating Akt-promoted cell migration. We propose a model in which APPL1 regulates 
cell migration and adhesion turnover my modulating Src-mediated phosphorylation of 
Akt (Figure 26).  
We used an APPL1 mislocalization mutant (APPL1-AAA) to show that the 
localization of APPL1 to endosomal membranes is critical to its function in modulating 
the amount of active Akt in cells as well as regulating cell migration and adhesion 
turnover.  A recent study has shown that APPL1 reduces the amount of active Akt at 
phagosomes by recruiting OCRL (an inositol 5-phosphatase) to these structures 
(Bohdanowicz, Balkin et al. 2012). There, OCRL reduces the available PIPs needed to 
activate Akt. It would be interesting to determine if APPL1, in HT1080 cells, reduces the 
amount of active Akt on endosomes. We will use the Akt activation FRET probe, Akind, 
to observe any changes in the activation of Akt on endosomal structures in APPL1 
expressing and control cells. We expect to see a reduction in Akt activation in the 
endosomal compartments when we express APPL1. This may explain why the APPL1 
mislocalization mutant had no effect, as it may no longer reduce this localized population 
of active Akt at endosomes.  
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Figure 26. Proposed model of APPL1-mediated effects on cell migration and 
adhesion turnover. Akt functions to promote cell migration and adhesion turnover once 
fully activated (phosphorylated). Src phosphorylates (P) Akt at tyrosines 315 and 326 
(Y315 and Y326). This promotes Akt activation and Akt is subsequently phosphorylated 
on threonine 308 and serine 473 (T308 and S473). Upon full activation, Akt then 
promotes an increase in migration speed and rate of adhesion turnover. APPL1 inhibits 
Src-mediated tyrosine phosphorylation of Akt and thereby inhibits Akt-promoted 
migration and adhesion turnover.  
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We discovered active Akt (as determined by threonine 308 phosphorylation state) 
is present in adhesions, which, as far as we know, has not been previously described. 
APPL1 expression reduces active Akt in adhesions, and we hypothesize this has an 
effect on adhesion turnover. It would be exciting to determine if APPL1 also affects the 
amount of tyrosine phosphorylated Akt in adhesions. We can determine this by immuno-
staining APPL1 expressing and control cells with an antibody that is specific to Akt 
phosphorylated at tyrosines 315 and 326. Tyrosine phosphorylation of Akt regulates its 
effects on migration. Therefore, we would expect that this would also be true for 
adhesion turnover. We can also use CA-Akt in which we mutate the important tyrosine 
phosphorylation sites (tyrosines 315 and 326), such that they can no longer be 
phosphorylated (tyrosine  phenylalanine), and ask what effect this has on Akt-
promoted adhesion turnover.  
 Tyrosine phosphorylation of Akt is mediated by the non-receptor tyrosine kinase 
Src (Chen, Kim et al. 2001; Choudhury, Mahimainathan et al. 2006). Here, we show that 
APPL1 can inhibit Src-mediated tyrosine phosphorylation of Akt. However, we do not 
understand the mechanism by which APPL1 inhibits Src function. Interestingly, when 
GFP-Src is co-expressed with mCherry-APPL1, we see these two proteins localized 
together in a subpopulation of vesicles (Figure 27). We would like to determine if APPL1 
is reducing Src-mediated tyrosine phosphorylation of Akt by altering Src localization, 
perhaps retaining Src in an endosomal compartment in which it can no longer act on Akt. 
We can use various fluorescently-tagged Src constructs to monitor the effects of APPL1 
on Src localization. In this context, it would also be interesting to look at the effects of the 
APPL1 mislocalization mutant (APPL1-AAA) on Src localization. We would expect that 
APPL1 localization to endosomal membranes would be required to alter Src localization 
in these structures. 
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Figure 27. APPL1 and Src colocalize in the same vesicles. When GFP-Src and 
mCherry-APPL1 are co-expressed in HT1080 cells, we see a subpopulation of APPL1 
vesicles that also contain Src (arrows).   
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Src typically exists in an auto-inhibited confirmation where its SH2 domain binds 
to a phosphorylation site within its C-terminus (Guarino 2010). It becomes activated 
when this phosphate is removed.  Src then adopts an open, activated conformation, and 
a phosphorylation event in the catalytic domain promotes full activation (Guarino 2010). 
Therefore, APPL1 may regulate Src function by modulating the activation state of Src. 
We can use phospho-specific antibodies against the key regulatory phosphorylation 
sites in Src to observe any effects APPL1 has on Src activation using Western blot 
analysis. Moreover, we can use these same antibodies, in conjunction with immuno-
fluorescent microscopy, to determine if APPL1 affects localized changes in active Src 
within individual cells. This may lead to a better understanding of how APPL1 modulates 
both Src and Akt function to regulate cell migration and adhesion turnover. 
 Finally, we have preliminary results suggesting that APPL1 expression leads to a 
decrease in the active form of the Rho GTPase family member Rac. This was observed 
in an active GTPase pulldown assay (Figure 28), see Bristow et al 2009 for methods. In 
addition, use of an active Rac FRET probe, similar to the Akind FRET probe, showed 
that APPL1 expressing cells have a reduced amount of active Rac (Figure 28). Further 
studies are needed to determine if this reduction in active Rac is also part of the 
APPL1/Src/Akt pathway that regulates cell migration and adhesion turnover. 
Interestingly, previous studies have shown that Akt can be upstream of Rac activation 
(Kobayashi, Hino et al. 2006). Moreover, Akt has been shown to regulate PAK and 
GSK3, both of which have been shown to regulate Rac activation, and both are 
involved in processes regulating cell migration, such as adhesion turnover (Zhou, Zhuo 
et al. 2003; Irie, Pearline et al. 2005; Kobayashi, Hino et al. 2006; Zhou, Tucker et al. 
2006). Therefore, these molecules are potential members of the APPL1 pathway that 
regulates cell migration and adhesion turnover, and represent potentially fruitful avenues 
for future study.  
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Figure 28. APPL1 reduces the amount of active Rac in cells. (Left, upper) Western 
blot showing APPL1 expression leads to a decrease in the amount of active Rac pulled 
down in an active GTPase assay compared to control cells. (Left, lower) Quantification 
of the relative amount of active Rac compared to Control is shown.  Error bars represent 
the S.E.M. from four separate experiments (*p<0.0001). (Right, upper) HT1080 cells 
were co-transfected with either mCherry (Control) or mCherry-APPL1 (APPL1) and the 
Rac activity FRET probe. Ratio images of FRET/CFP are shown in pseudo-color (warm 
colors correspond to higher levels of active Rac compared to cooler colors).  (Right, 
lower) Quantification of the average FRET/CFP ratio for cells co-transfected with either 
mCherry or mCherry-APPL1 and the Rac FRET probe is shown. Error bars represent 
the S.E.M. from greater than 16 cells (*p=0.0008). 
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